ESPE Abstracts
Scientific Programme, ePosters & Abstracts
Menu
Search
Issues/Conferences
Cite
Contact
Disclaimer
Search
Issues/Conferences
Cite
Contact
Disclaimer
Previous issue
|
Volume 94
|
ESPE2021
|
Next issue
59th Annual ESPE (ESPE 2021 Online)
Online,
22 Sept 2021 - 26 Sept 2021
All volumes
0098 ESPE2024
0097 ESPE2023
0095 ESPE2022
0094 ESPE2021
0092 ESPE2019
0089 ESPE2018
0086 ESPE2016
0084 ESPE2015
0082 ESPE2014
The 59th ESPE Annual Meeting will now be held online in September 2021.
Summary
Programme
eposters
Abstracts
Contents
Plenary Lectures
A kiss before sex
A Kiss before Sex
hrp0094pl1
Coming soon: new drugs for treatment of youth with type 2 diabetes
New Drugs for Youth with Type 2 Diabetes
hrp0094pl2
Iodine deficiency: A public health issue
Iodine deficiency: A public health issue
hrp0094pl3
Development of novel therapies for obesity
Development of novel therapies for obesity
hrp0094pl4
Advances and Challenges in the Care of Transgender/Gender Diverse Youth
Advances and Challenges in the Care of Transgender/Gender Diverse Youth
hrp0094pl5
The current state of epigenetic research in humans: Promise and reality
The current state of epigenetic research in humans: Promise and reality
hrp0094pl6
Novel insights into weight regulation
Novel insights into weight regulation
hrp0094pl7
The long-term effects of adolescent obesity
The Long term effects of adolescent obesity
hrp0094pl8
Symposia
Endocrine Hypertension - Aetiology Directed Management
Pathogenesis of Familial and Sporadic Hyperaldosteronism: New Concepts Involving Ion Channels
hrp0094s1.1
Abstract unavailable
hrp0094s1.2
Recent Breakthroughs in our Understanding of Calcium and Phosphate Homeostasis
Circadian rhythms of skeletal homeostasis.
hrp0094s2.1
Calciotropic and non-calciotropic roles of the calcium sensing receptor
hrp0094s2.2
Management of Rare Obesity
Iodine deficiency: A public health issue
hrp0094s3.1
Hypothalamic Obesity in Craniopharyngioma
hrp0094s3.2
Recent Developments in Congenital Adrenal Hyperplasia
Abstract unavailable
hrp0094s4.1
Abstract unavailable
hrp0094s4.2
Novel Therapies in Endocrinology
Novel Therapies in the Treatment of Congenital Hyperinsulinism
hrp0094s5.1
Abstract unavailable
hrp0094s5.2
Bone Formation: The Growth Plate and Beyond
Epigenetic regulation of the growth plate
hrp0094s6.1
Growth Plate: New insights in the origin and function of the growth plate
hrp0094s6.2
The Molecular Basis of Rare Endocrine Disorders
Abstract unavailable
hrp0094s7.1
Abstract unavailable
hrp0094s7.2
Management of Childhood Brain Tumours
Novel Insights Into the Management of Cranial Diabetes Insipidus
hrp0094s8.1
Abstract unavailable
hrp0094s8.2
Surgical Management of Endocrine Disorders
Abstract unavailable
hrp0094s9.1
Abstract unavailable
hrp0094s9.2
Pathways to Improved Diagnosis and Management of Hypothalamo-Pituitary Disorders
Abstract unavailable
hrp0094s10.1
Delayed puberty: A genetic condition?
hrp0094s10.2
Calcium and Phosphate Beyond Bone
Phosphate toxicity: focus on medial vascular calcification
hrp0094s11.1
Vitamin D and male reproduction
hrp0094s11.2
Epigenetics and Genetics in Endocrine Disorders
Epigenetics, imprinting and growth
hrp0094s12.1
The role of genetic analysis in primary ovarian failure
hrp0094s12.2
Joint ESPE/ISPAD Symposium: Novel Technologies in the Treatment of Diabetes
Latest developments in closed loop technology
hrp0094s13.1
Abstract unavailable
hrp0094s13.2
Meet the Expert
Thyroid hormone resistance syndromes
Thyroid hormone resistance syndromes
hrp0094mte1
Diagnosis and management of a child with pituitary adenoma
Diagnosis and management of a child with pituitary adenoma
hrp0094mte2
Management of a child with post-neurosurgical hyponatraemia
Management of a child with post-neurosurgical hyponatraemia
hrp0094mte3
Cystic Fibrosis-related diabetes
Cystic Fibrosis-related diabetes
hrp0094mte4
Management of MEN1 in children and adolescents
Management of MEN1 in Children and Adolescents
hrp0094mte5
Autoimmune endocrinopathy
Autoimmune endocrinopathy
hrp0094mte6
Endocrine and osteoporosis management of boys with DMD
Endocrine and osteoporosis management of boys with DMD
hrp0094mte7
Real-life diabetes management during exercise
Real-life diabetes management during exercise
hrp0094mte8
How Do I
How Do I Session 1
Non-Classic congenital adrenal hyperplasia (NCCAH) - From Childhood to Adulthood
hrp0094hdi1.1
Abstract unavailable
hrp0094hdi1.2
Abstract unavailable
hrp0094hdi1.3
How Do I Session 2
Abstract unavailable
hrp0094hdi2.1
Abstract unavailable
hrp0094hdi2.2
Advise patients on insulin dosing for real meals.
hrp0094hdi2.3
Controversies
Stem Cell Reprogramming, IPS Cells
Abstract unavailable
hrp0094con1.1
Abstract unavailable
hrp0094con1.2
Should children with isolated idiopathic GHD be retested in early/mid-puberty, rather than wait until adult height is achieved?
Should children with isolated idiopathic GHD (IIGHD) be retested in early/mid-puberty, rather than wait until adult height is achieved? (PRO)
hrp0094con2.1
Should children with isolated idiopathic GHD (IIGHD) be retested in early/mid-puberty, rather than wait until adult height is achieved? (AGAINST)
hrp0094con2.2
GPED
The use of long-acting insulin analogues in low and middle income countries
For the use of long acting insulin analogues in low and middle income countries
hrp0094gped1.1
Abstract unavailable
hrp0094gped1.2
Young Investigators
Young Investigators
Identification of novel genetic causes of familial central precocious puberty
hrp0094yi1.1
Early life events and postnatal effects from infancy to childhood
hrp0094yi1.2
Genetics and endocrine phenotypes of the MEHMO syndrome
hrp0094yi1.3
Genetics and endocrine phenotypes of the MEHMO syndrome
hrp0094yi1.4
Vegf-A mRNA transfection to improve islet graft revascularization
hrp0094yi1.5
Working Group Symposia
ESPE Working Group on Bone and Growth Plate (BGP) Symposium
Abstract unavailable
hrp0094wg1.1
Craniosynostoses - genes and bone biology
hrp0094wg1.2
ESPE Working Group on Obesity (OWG) Symposium
Environmental obesogens
hrp0094wg2.1
Maternal obesity and offspring health
hrp0094wg2.2
ESPE Working Group on Diabetes Technology (DT) Symposium
Abstract unavailable
hrp0094wg3.1
Decision Support System for the diabetologists - practical experience
hrp0094wg3.2
The impact of fear of hyperglycemia in parents of children with type 1 diabetes mellitus on overall glycemic control
hrp0094wg3.3
ESPE Working Group on Disorders of Sex Development (DSD) Symposium
New insights into sex differentiation and their relevance to disorders of sex development
hrp0094wg4.1
Advances in the Measurement of Steroid Hormones
hrp0094wg4.2
ESPE Working Group on Paediatric and Adolescent Gynaecology (PAG) Symposium
Deciphering the genetics of central precocious puberty
hrp0094wg5.1
Abstract unavailable
hrp0094wg5.2
ESPE Working Group on Gender Incongruence (GI) Symposium
Abstract unavailable
hrp0094wg6.1
Abstract unavailable
hrp0094wg6.2
ESPE Working Group for Paediatric Endocrine Nurses (ESPEN) Symposium
Abstract unavailable
hrp0094wg7.1
Abstract unavailable
hrp0094wg7.2
Nursing care for the child with gender dysphoria
hrp0094wg7.3
ESPE Working Group on Turner Syndrome Symposium
Abstract unavailable
hrp0094wg8.1
Turner syndrome and hormone replacement therapy
hrp0094wg8.2
Blood Pressure in Turner Syndrome - a practical approach
hrp0094wg8.3
Endo-ERN Symposium
Endo-ERN Symposium
Update on the consensus on Congenital Hypothyroidism: a patient-centered approach
hrp0094ern1.1
Patient expectation and unmet needs in XLH
hrp0094ern1.2
Abstract unavailable
hrp0094ern1.3
ESPE Yearbook Sessions
Year of Paediatric Endocrinology 1
Abstract unavailable
hrp0094yb1.1
Abstract unavailable
hrp0094hb1.2
Abstract unavailable
hrp0094yb1.3
Growth and Growth Factors
hrp0094yb1.4
Bone, Growth Plate and Mineral Metabolism
hrp0094yb1.5
Year of Paediatric Endocrinology 2
DSD and Transgender - Updates 2021
hrp0094yb2.1
Antenatal and Neonatal Endocrinology
hrp0094yb1.2
Abstract unavailable
hrp0094yb2.3
Oncology and Chronic Disease
hrp0094yb2.4
Abstract unavailable
hrp0094yb2.5
Year of Paediatric Endocrinology 3
Abstract unavailable
hrp0094yb3.1
Abstract unavailable
hrp0094yb3.2
Abstract unavailable
hrp0094yb3.3
Abstract unavailable
hrp0094yb3.4
Abstract unavailable
hrp0094yb3.5
Henning Andersen Prize Winners
A Global Natural History Study of Fibrodysplasia Ossificans Progressiva (FOP): 36-Month Outcomes in Participants Aged <25 Years
A Global Natural History Study of Fibrodysplasia Ossificans Progressiva (FOP): 36-Month Outcomes in Participants Aged <25 Years
hrp0094ha1
Biphasic Pattern of Circulating Reproductive Hormones in Female Infants – The Longitudinal COPENHAGEN Minipuberty Study
Biphasic Pattern of Circulating Reproductive Hormones in Female Infants – The Longitudinal Copenhagen Minipuberty Study
hrp0094ha2
Free Communications
Adrenal
Salivary profiles of 11 oxygenated androgens follow a diurnal rhythm in patients with congenital adrenal hyperplasia
hrp0094fc1.1
Variation of glucocorticoid dose and biomarkers in children with congenital adrenal hyperplasia - longitudinal analysis of real world data from the I-CAH registry
hrp0094fc1.2
Re-appraising the use of urinary steroid profiles for assessing therapy control in children with 21-hydroxylase deficiency - results from the CAH-UK cohort study
hrp0094fc1.3
Acute Illness and Death in Children with Adrenal Insufficiency
hrp0094fc1.4
Outcome of COVID-19 infections in patients with adrenal insufficiency
hrp0094fc1.5
Tumor DNA methylation profiling as a prognostic marker for pediatric patients with adrenocortical tumors
hrp0094fc1.6
Fat, Metabolism and Obesity
Efficacy and Safety Results of a Phase 2 Trial of Setmelanotide in Obesity Due to
SH2B1
Variants and 16p11.2 Deletion Syndrome
hrp0094fc2.1
Phase 3 Trial of Setmelanotide in Participants With Bardet-Biedl Syndrome: Placebo-Controlled Results
hrp0094fc2.2
A Phase 2 Trial of the Melanocortin-4 Receptor Agonist Setmelanotide in Obesity Due to SRC1 Insufficiency: Body Weight, Body Mass Index Z Score, and Safety Results
hrp0094fc2.3
PTEN germline mutations lead to adipose tissue overgrowth mediated via FOXO1 and SREBP1.
hrp0094fc2.4
Reference values for longitudinal body composition in children aged 0-5 years, using Dual-energy X-ray (DXA) absorptiometry
hrp0094fc2.5
Association between MRI Evidence of Hypothalamic Gliosis and Pubertal Development in Girls with Obesity
hrp0094fc2.6
Growth Disorders
iPPSD: focus on neonatal features, preliminary data from a retrospective analysis of a large cohort of patients.
hrp0094fc3.1
Identification of a FBN1 variant in a pedigree affected with Severe Short Stature with a Mild Form of Geleophysic Dysplasia Type 2
hrp0094fc3.2
Genetic characterization of a cohort of children with short stature
hrp0094fc3.3
Prospective genetic analysis by a targeted gene panel of a cohort of patients classified as idiopathic short stature (ISS)
hrp0094fc3.4
Clinical profiles and genetic spectra of 814 Chinese children with short stature
hrp0094fc3.5
Growth patterns in children with Mucopolysaccharidosis type I-Hurler after haematopoietic stem cell transplantation: comparison with untreated patients
hrp0094fc3.6
Diabetes
Role of physical activity and sedentary behavior on early markers of cardiovascular disease in Canadian adolescents with and without type 1 diabetes: the CARDEA study
hrp0094fc4.1
A Randomised Controlled Cross-Over Trial of the Hybrid Closed-Loop Insulin Delivery System Diabeloop vs. Sensor-Augmented Pump Therapy in Children Aged 6-12 Years
hrp0094fc4.2
Aldosterone and pro-atrial natriuretic peptide kinetics in response to rehydration in children with diabetic ketoacidosis
hrp0094fc4.3
Effect of newer CFTR modulator therapy on glycaemic control in adolescents with CFRD
hrp0094fc4.4
Molecular Genetic Diagnosis and Research of Candidate Genes by Targeted Next Generation Sequence Analysis and Whole Exome Sequencing Method in Monogenic Diabetes: MODY-TURK Project
hrp0094fc4.5
Clinical and genetic heterogeneity of
HNF4A/HNF1A
mutations in a multicentre paediatric cohort
hrp0094fc4.6
Sex Development and Gender Incongruence
Growth and growth reduction in transgirls
hrp0094fc5.1
Unexpected impact of sex hormones on B-cells in trans- and cis-gendered healthy young people
hrp0094fc5.2
Fetal Anogenital Distance (AGD) by Ultrasonography: a Marker of Early Androgen Exposure
in utero
?
hrp0094fc5.3
Reproductive hormone levels in Minipuberty as a predictor of Testicular Endocrine Function and Penile Length in Healthy Young Men: An 18-year longitudinal Cohort Study
hrp0094fc5.4
Individuals with
NR5A1 (SF1)
mutations and atypical sex development and their asymptomatic family member carriers are at high risk of hyposplenism
hrp0094fc5.5
Investigation of The Molecular Genetic Causes Of Non-Syndromic Premature Ovarian Failure By Next Generation Sequence Analysis
hrp0094fc5.6
Bone and Mineral Metabolism
Evaluation of the potential benefits of biphosphonate treatment on symptomatic vertebral fractures in children treated for acute lymphoblastic leukemia
hrp0094fc6.1
Long-term effectiveness of PTH(1-34) infusion therapy for autosomal dominant hypocalcaemia type 1.
hrp0094fc6.2
Off-label use of cinacalcet in pediatric primary hyperparathyroidism: a French multi-centre experience
hrp0094fc6.3
Use of Aids, Assistive Devices and Adaptations (AADAs) by Individuals Aged <25 Years with Fibrodysplasia Ossificans Progressiva (FOP): 36-Month Results from a Global Natural History Study (NHS)
hrp0094fc6.4
What is the natural history of cervicomedullary compression without signal change in infants with achondroplasia? Investigating foramen magnum stenosis evolution.
hrp0094fc6.5
Use of lateral DEXA scanning for identifying and monitoring vertebral fractures in patients affected by Duchenne Muscular Dystrophy.
hrp0094fc6.6
Fetal Endocrinology and Multisystem Disorders
The Use Of e-REC For Capturing The Occurrence Of COVID-19 Infections In People With Rare Endocrine Conditions
hrp0094fc7.1
Maternal, rather than fetal, genetic variation in vitamin D metabolism is associated with umbilical cord blood 25-hydroxyvitamin D in pregnancies supplemented with cholecalciferol: findings from the MAVIDOS randomized controlled trial
hrp0094fc7.2
European Training Requirements for Competency in Paediatric Endocrinology and Diabetes 2021
hrp0094fc7.3
Endocrine sequelae in 157 paediatric survivors of haematopoietic stem cell transplantation
hrp0094fc7.4
Rituximab therapy in Rapid-Onset Obesity, Hypothalamic Dysfunction, Hypoventilation, and Autonomic Dysregulation (ROHHAD) Syndrome
hrp0094fc7.5
Reassessment of 18F-DOPA PET cut-offs in congenital hyperinsulinism
hrp0094fc7.6
Neuroendocrinology
Combined omic analysis revealed autism-linked
NLGN3
as new candidate gene associated to GnRH neuron development and disease.
hrp0094fc8.1
Recessive
PRDM13
mutations result in hypogonadotropic hypogonadism and cerebellar hypoplasia
hrp0094fc8.2
A novel clinical risk score that can accurately predict recurrence of craniopharyngioma - a multicentre cohort study
hrp0094fc8.3
Cerebral infarction in childhood-onset craniopharyngioma patients: results of KRANIOPHARYNGEOM 2007
hrp0094fc8.4
Bardet-Biedl Syndrome: A retrospective study of progression through puberty
hrp0094fc8.5
Efficacy and Safety of Corifollitropin Alfa in Combination with Human Chorionic Gonadotropin for Initiation or Restoration of Puberty in Adolescent Males Aged 14 to < 18 Years with Hypogonadotropic Hypogonadism
hrp0094fc8.6
Growth Hormone and IGFs
How to interpret growth hormone stimulation test results in children and adolescents with overweight and obesity? A systematic review and meta-analysis and evidence-based proposal for weight-status adjusted cut-offs
hrp0094fc9.1
A simple model with height and age at start of treatment with recombinant human growth hormone can accurately predict future growth in children with growth disorders
hrp0094fc9.2
Once-weekly somapacitan versus daily growth hormone in growth hormone deficiency: 3 year efficacy and safety results from REAL 3, a randomised controlled phase 2 trial
hrp0094fc9.3
Optimising adherence using a connected injection device can improve growth outcomes: Evidence from real-world data on 11 million injections in 20,000 patients with growth disorders
hrp0094fc9.4
Dynamic Changes in Growth and IGF-I During the First Year of Life; A Longitudinal Study of 233 healthy Danish Infants
hrp0094fc9.5
Impact of pre-transplant serum-IGF-1 on hematopoietic stem cell transplantation outcome in pediatric cancer patients
hrp0094fc9.6
Thyroid
Natural history of congenital hypothyroidism in the last two decades: what is changing? Experience of a single tertiary Italian paediatric centre.
hrp0094fc10.1
Prevalence and outcome of Congenital Central Hypothyroidism: A Multicenter Study
hrp0094fc10.2
Genetic analyses in patients having congenital hypothyroidism with gland-in-situ by next-generation sequencing
hrp0094fc10.3
Towards a novel genetic model for Congenital Hypothyroidism due to thyroid dysgenesis
hrp0094fc10.4
Adjuvant Rituximab - exploratory trial in young people with Graves’ disease
hrp0094fc10.5
Clinical features and long-term follow up of childhood papillary thyroid cancer (PTC): a single reference-center experience
hrp0094fc10.6
ePoster Category 1
Adrenal A
Optimizing the timing of highest hydrocortisone dose in children and adolescents with 21-hydroxylase deficiency
hrp0094p1-1
Adrenocortical hormone profiles do not predict the molecular etiology in non-CAH primary adrenal insufficiency
hrp0094p1-2
Growth-Related Characteristics of Patients <18 Years of Age with Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency (21OHD): Real-World Evidence from the I-CAH Registry
hrp0094p1-3
Depression among insured children and young adults in the United States with congenital adrenal hyperplasia
hrp0094p1-4
Alterations in resting-state functional connectivity in patients with congenital adrenal hyperplasia
hrp0094p1-5
International practice of therapy monitoring in congenital adrenal hyperplasia - Real World data from the I-CAH registry
hrp0094p1-6
Brain activity during working memory in congenital adrenal hyperplasia
hrp0094p1-7
Long-term Cardiometabolic Morbidity In Young Adults With Classic 21-Hydroxylase Deficiency Congenital Adrenal Hyperplasia
hrp0094p1-8
Backdoor Pathway hormones and 11-oxygenated Androgens are elevated in Patients with 21-hydroxylase deficiency
hrp0094p1-9
Glucose regulation in children with primary adrenal insufficiency: preliminary data.
hrp0094p1-10
Bone A
Bone and endocrine monitoring in boys with Duchenne Muscular Dystrophy
hrp0094p1-11
Real-world clinical profiles of children with hypophosphatasia (HPP) from the Global HPP Registry
hrp0094p1-12
Characterisation and phenotype-genotype associations of a large cohort of patients with pseudohypoparathyroidism type 1A and 1B
hrp0094p1-13
Tumor induced osteomalacia, a rare and complex condition with more treatment options, exemplified in two patients.
hrp0094p1-14
Vitamin D status and guidelines in Paediatric Inflammatory Multisystem Syndrome Temporarily associated with SARS-CoV-2 (PIMS-TS)
hrp0094p1-15
Leptin to adiponectin ratio at the age of 12 is negatively associated with lumbar spine bone mineral apparent density independently of body fat mass in 18-year old males.
hrp0094p1-16
Clinical Spectrum of Hypomagnesemia type 1 (HOMG1) due to Novel
TRPM6
mutations
hrp0094p1-17
A rare cause of hypercalcemia: Congenital Lactase Deficiency
hrp0094p1-18
Acetazolamide treatment in a patient with pseudohypoparathyroidism with venous calcification
hrp0094p1-19
A novel TRPM6 variant (c.3179T>A) causing familial hypomagnesemia with secondary hypocalcemia
hrp0094p1-20
Diabetes A
Incidence of Type 1 Diabetes in Children and Adolescents during the Covid-19 Pandemic in Germany: Results from the DPV registry
hrp0094p1-21
Early meal reporting enhances post-prandial glycaemic balance but remains underused in teenagers with artificial pancreas
hrp0094p1-22
Capillary blood sample collection at home for HbA1c measurements during the COVID-19 pandemic in children with diabetes mellitus
hrp0094p1-23
Resolution of feeding problems in patients with congenital hyperinsulinism
hrp0094p1-24
Longitudinal Auxological Recovery and Reduced Neurodevelopmental Problems in Hyperinsulinaemic Hypoglycaemia
hrp0094p1-25
Efficacy and Tolerability of GLP-1 Receptor Agonists in Children and Adolescents with Obesity
hrp0094p1-26
The SARS-CoV-2 Pandemic Is Associated With Increased Severity Of Presentation Of Childhood Onset Type 1 Diabetes Mellitus: A Multicentre Study Of The First COVID-19 Wave
hrp0094p1-27
Glycemic control and changes in habits in patients with type 1 diabetes during the lockdown due to the COVID-19 pandemic
hrp0094p1-28
Incidence and severity of new-onset paediatric Type 1 diabetes in the COVID-19 pandemic - a UK multicentre perspective
hrp0094p1-29
Metabolic Control and Health-Related Quality of Life in Children with Diabetes Mellitus during the COVID-19 Pandemic: Results from a Prospective Swiss Cohort Study
hrp0094p1-30
Fat, Metabolism and Obesity A
Efficacy and Safety of Setmelanotide in Individuals With Obesity Due to POMC or LEPR Deficiency: Phase 3 Results From Pivotal and Supplemental Cohorts
hrp0094p1-31
Sex hormones drive changes in lipoprotein profiles in adolescents; early implications for cardiovascular disease risk
hrp0094p1-32
Metabolomics in early life and the association with body composition at age 2 years
hrp0094p1-33
High prevalence of undiagnosed metabolic dysfunction among children and adolescents with obesity in China
hrp0094p1-34
The possible association of the apoptotic marker APO1/Fas with predisposition to metabolic syndrome and mean platelet volume in children
hrp0094p1-35
Reversal of metabolic derangement in patient with congenital generalized lipodystrophy treated with metreleptin
hrp0094p1-36
The effect of trans-palmitoleic acid on lipid accumulation and the fatty acid synthase gene expression in hepatocytes
hrp0094p1-37
Are Serum Spexin Levels Associated With Metabolic Syndrome Antecedents In Obese Adolescents?
hrp0094p1-38
Serum endocan as a predictive biomarker of cardiovascular risk in obese pediatric patients
hrp0094p1-39
Liraglutide for the Management of Childhood Obesity
hrp0094p1-40
Sex Endocrinology and Gonads A
Phenotypic Characteristics of Patients with 45,X/46,XY Mosaicism: Growth, Gonadal Pathology and Tumour Risk
hrp0094p1-41
Disorders of sex development: clinical and genetic heterogeneity
hrp0094p1-42
Broad range of phenotypes in an international cohort of 75 DSD individuals with SF-1/NR5A1 variants
hrp0094p1-43
Adolescents and young adult men with non-syndromic hypospadias: testicular function and in-depth genetic screening
hrp0094p1-44
Bilateral testicular regression: genetic etiology and outcome in a large Belgian series
hrp0094p1-45
Endocrine & Molecular Genetic Findings In XY Boys Investigated For A Disorder Of Sex Development: the Glasgow Experience
hrp0094p1-46
STK11
gene variant (Peutz-Jeghers Syndrome) presenting with unilateral pre-pubertal gynaecomastia and macro-orchidism without muco-cutaneous pigmentation or gastrointestinal symptoms.
hrp0094p1-47
Gonadal Outcome in 17beta-HSD deficiency and 5alpha-reductase deficiency
hrp0094p1-48
Biallelic
PPP2R3C
mutations are associated with partial and complete gonadal dysgenesis in 46,XY and 46,XX individuals
hrp0094p1-49
Pathogenic variants in the human m
6
A reader YTHDC2 are associated with primary ovarian insufficiency
hrp0094p1-50
Bone B
A Global Natural History Study (NHS) of Fibrodysplasia Ossificans Progressiva (FOP): Normal Long Bone Growth and Abnormalities in Younger Patients over 36 Months
hrp0094p1-51
Impact of Vertebral Fracture on Auxological Profile and Insulin-like Growth Factors of Children after Acute Lymphoblastic Leukemia Treatment
hrp0094p1-52
Growth and Puberty in Patients with Osteogenesis Imperfecta
hrp0094p1-53
Decreased bone mineral density in children receiving long-term anticoagulation is associated with pubertal development
hrp0094p1-54
Premature epiphyseal fusion induced by a retinoic acid agonist in a young girl with fibrodysplasia ossificans progressiva
hrp0094p1-55
Chondrocyte regulating and other growth plate genes are invaluable growth regulators: a study on children with short stature from 55 consanguineous families
hrp0094p1-56
High rate of positive genetic findings in children born small for gestational age with persistent short stature (SGA-SS): Growth plate genes as key regulators of intrauterine growth
hrp0094p1-57
AAV liver gene therapy-mediated inhibition of FGF23 signaling as a therapeutic strategy for X-linked hypophosphatemia
hrp0094p1-58
Cartilage -specific knockout of SIRT1 significantly reduces bone quality and catch-up growth efficiency
hrp0094p1-59
Mosaic
PHEX
variants are important causes of X-linked hypophosphataemic rickets.
hrp0094p1-60
Diabetes B
Timing of Hypoglycaemia in Patients with Hyperinsulinism (HI): Extension of the Digital Phenotype
hrp0094p1-61
Epidemiology of type 1 diabetes in children and adolescents: a 50-year, single center experience
hrp0094p1-62
Comparison of triglyceride and glucose index and homeostatic model assessment for insulin resistance in children and adolescents with type 2 diabetes mellitus
hrp0094p1-63
Initial Neutrophil/Lymphocyte and Lymphocyte/Monocyte Ratios Can Predict Future Insulin Need in Newly Diagnosed Type 1 Diabetes Mellitus
hrp0094p1-64
Efficacy of Use of Continuous Glucose Monitoring System in patients with Congenital Hyperinsulinism
hrp0094p1-65
Mortality in children with monogenic diabetes
hrp0094p1-66
The Molecular Genetic Etiology by Whole Exome Sequence Analysis in Cases With Familial Type 1 Diabetes Mellitus without HLA Haplotype Predisposition or Incomplete Predisposition
hrp0094p1-67
Birth weight and diazoxide unresponsiveness strongly predict the likelihood of congenital hyperinsulinism due to a mutation in ABCC8 or KCNJ11
hrp0094p1-68
Oxidized lipid-associated protein damage in children and adolescents with type 1 diabetes mellitus: new diagnostic/prognostic clinical markers.
hrp0094p1-69
Change in HbA1C predicts future abnormal Oral Glucose Tolerance Tests in children and adolescents with Cystic Fibrosis.
hrp0094p1-70
Fetal Endocrinology and Multisystem Disorders A
Morning salivary cortisol and stress response in term and preterm infants hospitalized in the intensive care unit.
hrp0094p1-71
Clinical characteristics of children with Congenital Hyperinsulinism: Results from the European Registries for Rare Endocrine Conditions (EuRRECa) Project
hrp0094p1-72
Minipuberty in born small for gestational age infants: a case control prospective pilot study
hrp0094p1-73
Pancreatic glucagon-like-peptide-1 receptor expression in congenital hyperinsulinism
hrp0094p1-74
Congenital hyperinsulinism diagnosed after 12 months can have a monogenic aetiology
hrp0094p1-75
Hyperinsulinemic Hypoglycemia in a child with Peroxisomal Biogenesis Disorder due to a Novel PEX1 mutation
hrp0094p1-76
Real-Time Continuous Glucose Monitoring in the Management of Neonates with Persistent Hypoglycemia
hrp0094p1-77
Hyperinsulinemic hypoglycemia due to biallelic mutations in the DNAJC3 gene
hrp0094p1-78
Concurrent hyperinsulinism and hypopituitarism in a 22 month old child due to a novel FOXA2 mutation
hrp0094p1-79
Sphingosine 1- phosphate lyase insufficiency syndrome (SPLIS) as a cause of primary adrenal insufficiency and primary hypogonadism
hrp0094p1-80
Pituitary A
Sporadic pituitary adenomas in young patients: clinical and molecular description
hrp0094p1-81
Cardiac remodeling in patients with childhood-onset craniopharyngioma - Results of HIT-Endo and KRANIOPHARYNGEOM 2000/2007
hrp0094p1-82
Pregnancies after childhood craniopharyngioma - Results of Kraniopharyngeom 2000/2007
hrp0094p1-83
Pituitary Duplication - A rare and heterogenous spectrum
hrp0094p1-84
Auxological and endocrine aspects in pediatric patients with type 1 Narcolepsy. Results of long-term follow-up in a pediatric endocrinology center
hrp0094p1-85
Adding a protease inhibitor to sampling tubes increases the acylated ghrelin and decreases the desacylated ghrelin levels in girls.
hrp0094p1-86
GHSR protects the emergence of limited sex differences in anxiety-related behaviors in adult mice after long term THC administration during peri-adolescence
hrp0094p1-87
Pituitary microadenomas in childhood - is follow-up with diagnostic imaging necessary?
hrp0094p1-88
The Pituitary Tumour Module: Developing a Condition Specific Module within the European Registries for Rare Endocrine Conditions (EuRRECa)
hrp0094p1-89
Craniopharyngiomas presenting as incidentalomas: results of KRANIOPHARYNGEOM 2007
hrp0094p1-90
Thyroid A
The effect of preoperative calcitriol prophylaxis on post-thyroidectomy hypocalcaemia in children
hrp0094p1-91
Emotional Intelligence scores in children and adolescents with subclinical hypothyroidism - correlation with serum serotonin and thyroid stimulating hormone (TSH) concentrations.
hrp0094p1-92
"Lympocyte population in children and adolescents affected by Graves’ disease. Potential predictive tool of disease severity"
hrp0094p1-93
Evaluation of children with intrathyroidal ectopic thymus
hrp0094p1-94
Prevalence and Characteristics of thyroid nodules in a pediatric population with congenital hypothyroidism
hrp0094p1-95
Thyroid storm and transient bulbar myopathy in a 22-month-old girl with Graves’ Disease
hrp0094p1-96
The association between serum Thyrotropin within the reference range and cardiometabolic risk in obese children
hrp0094p1-97
Hypothyroid Screening in Children with Down Syndrome - A Service Evaluation
hrp0094p1-98
Early adiposity rebound in children with congenital hypothyroidism diagnosed by newborn screening
hrp0094p1-99
Serum fibroblast growth factor 21 (FGF-21) levels of children and adolescents with Hashimoto’s thyroiditis, before and after L-thyroxin medication
hrp0094p1-100
Adrenal B
The management of adrenal cell carcinoma in a single tertiary centre: 25 year experience
hrp0094p1-101
Correlation of 11-oxygenated C19 androgens with the clinical and biochemical characteristics in premature adrenarche
hrp0094p1-102
Leukocyte telomere length in children with Congenital Adrenal Hyperplasia
hrp0094p1-103
[rdquo]Cortison-loop[rdquo] is an educational tool, which helps ensure the quality of care for children with adrenal insufficiency.
hrp0094p1-104
The genetic etiology of ACTH-dependent aldosterone hypersecretion in hypertensive patients without Primary Aldosteronism
hrp0094p1-105
Plasma Proteomics in Healthy Subjects with Differences in Tissue Glucocorticoid Sensitivity Identifies a Novel Proteomic Signature
hrp0094p1-106
Cortoic Acids: Renaissance of a Forgotten Class of Steroids
hrp0094p1-107
Circadian rhythm of cortisol in saliva in obese children with clinical signs of hypercortisolism
hrp0094p1-108
Plasma steroid panel with liquid chromotography-mass spectrometry (LC/MS-MS) method: utilization in differential diagnosis of hyperandrogenism
hrp0094p1-109
Current Management Of Acute Adrenal Insufficiency Related Adverse Events In Children- Results Of An International Survey Of Specialist Centres
hrp0094p1-110
Fat, Metabolism and Obesity B
Insulin resistance following childhood craniopharyngioma may influence neural response to food cues in food reward-related brain regions: a preliminary investigation.
hrp0094p1-111
Evaluation of the BigO behavioral indicators in overweight and obese children and adolescents
hrp0094p1-112
Are you considering Idiopathic Intracranial Hypertension when evaluating a patient with obesity?
hrp0094p1-113
EuRRECa Registry Genetic Obesity Survey Results
hrp0094p1-114
Circulating C1q Complement/TNF-Related Protein (CTRP)-13 Levels in Obese Children and Its Relationship with Metabolic Disorders
hrp0094p1-115
An Evidence-based Framework to Evaluate Melanocortin-4 Receptor (MC4R) Pathway Relevance for Obesity-associated Genes
hrp0094p1-116
Serum Fibroblast Growth Factor 23 and Klotho concentrations in children and adolescents with obesity.
hrp0094p1-117
Rare heterozygous variants in genes of the leptin-melanocortin satiety pathway contribute to childhood obesity
hrp0094p1-118
Diagnostic precision of the Tri-Ponderal Mass Index (kg/m
3
) to identify the metabolic risk phenotype in obese children and adolescents
hrp0094p1-119
Monogenic obesity in children: focusing on
SH2B1
deletion
hrp0094p1-120
Growth A
Higher rates of non-skeletal complications in achondroplasia compared to the general population: a UK matched cohort study using the CPRD database
hrp0094p1-121
Short stature in Protein Arginine Methyltransferase 7 (PRMT7) mutations: first evidences of growth response to rGH treatment
hrp0094p1-122
Growth and nutrition improvement with recombinant growth hormone in prepubertal patients with Silver-Russell syndrome
hrp0094p1-123
Management of endocrine aspects of Noonan syndrome across Europe: A subanalysis of a European clinical practice survey
hrp0094p1-124
PROPEL2: a phase 2, open-label, dose-escalation and dose-expansion study of infigratinib in children with achondroplasia (ACH)
hrp0094p1-125
Identification and tissue-specific characterization of novel SHOX-regulated genes in zebrafish highlights SOX family members among other genes
hrp0094p1-126
Evaluation of early puberty in boys and girls with Silver-Russell Syndrome: Discordance between testicular growth and pituitary-gonadal hormones in male cases
hrp0094p1-127
Evaluation of Persistent Short Stature in Children Born Small for Gestational Age without Catch-up Growth
hrp0094p1-128
Computer-aided facial analysis as a tool to identify patients with Silver-Russell syndrome and Prader-Willi syndrome
hrp0094p1-129
Study design and baseline characteristics of children enrolled in PROPEL: A prospective clinical assessment study in children with achondroplasia (ACH)
hrp0094p1-130
Growth Hormone and IGFs A
ABSTRACT WITHDRAWN
hrp0094p1-131
Use of growth hormone therapy in short patients born small for gestational age: data from real-life French clinical practice
hrp0094p1-132
Efficacy and safety profile of recombinant insulin like growth factor 1 (rh IGF1) therapy: A long term follow up study at a single tertiary centre.
hrp0094p1-133
Starting recombinant human growth hormone treatment at an early age improves adherence and catch-up growth in patients with growth disorders, and highlights the importance of the new guideline on referral of short children to paediatric care
hrp0094p1-134
Long-term safety of growth hormone in adults and adolescents with growth hormone deficiency: An overview of the full-cohort in KIMS
hrp0094p1-135
Comparison of actual GH dose with labeled dose in children with short stature based on the LG Growth Study
hrp0094p1-136
Persistently increased IGF-I levels and excellent auxological response despite low doses of recombinant growth hormone in a GH-deficient patient with a heterozygous variant of the growth hormone receptor (GHR) gene
hrp0094p1-137
Safety and effectiveness of pediatric growth hormone therapy: Results from the full cohort in KIGS
hrp0094p1-138
The effect of growth hormone therapy on linear growth and weight gain in children with growth hormone deficiency vs idiopathic short stature (ISS) a controlled study
hrp0094p1-139
Linear growth response top Growth hormone therapy in underweight versus normal-weight children with idiopathic short stature (ISS).
hrp0094p1-140
Sex Endocrinology and Gonads B
Screening of serum differential proteins in girls with rapidly progressing central precocious puberty with TMT quantitative proteomics
hrp0094p1-141
Investigation of primary adrenal insufficiency (PAI) in children with 46,XY differences in sex development (DSD)
hrp0094p1-142
Current clinical practice of prenatal dexamethasone treatment in at risk pregnancies for classic 21 hydroxylase deficiency in Europe
hrp0094p1-143
Ovarian AMH production is transiently affected in pubertal and prepubertal girls with acute lymphoblastic leukaemia and non-Hodgkin lymphoma receiving chemotherapy: a prospective, longitudinal study
hrp0094p1-144
Serum anti-Mullerian hormone as a marker of ovarian reserve among childhood cancer survivors
hrp0094p1-145
Reaching a definitive diagnosis of hypogonadotropic hypogonadism - experience of a multidisciplinary diagnostic service
hrp0094p1-146
A pre-analytical challenge to determine estradiol in children: A monovette systematically causing increased estradiol-concentrations in LC-MS/MS analysis
hrp0094p1-147
Central precocious puberty and sleep patterns in COVID-19 outbreak
hrp0094p1-148
QUERY by TELARQUIA: Has there been an increase due to the SARS-COV19 pandemic?
hrp0094p1-149
Androgen insensitivity without an androgen receptor mutation: results from a large cohort study
hrp0094p1-150
Fetal Endocrinology and Multisystem Disorders B
Duration of Fasting Studies Required to Demonstrate a Cure for Patients with Focal Congenital Hyperinsulinism.
hrp0094p1-151
Impact of gestational weight gain on methylation of imprinted genes in umbilical cord and its relationship with postnatal growth and metabolism
hrp0094p1-152
Different faces of minipuberty in preterm twin girls
hrp0094p1-153
The Evaluation of Accuracy and Effectiveness of Newborn Screening for Congenital Adrenal Hyperplasia in Lithuania
hrp0094p1-154
Pediatric Inflammatory Multisystemic Syndrome in Brazil: sociodemographic characteristics and risk factors to death
hrp0094p1-155
Molecular and phenotypic profile of Alstrom syndrome in Chinese patients:results from a Chinese cohort
hrp0094p1-156
Endocrine Monitoring and Outcome After Therapy In Childhood Survivors of Central Nervous System Tumours
hrp0094p1-157
Low adrenal androgen levels in patients with and without primary adrenal insufficiency in APECED (APS1)
hrp0094p1-158
Clinical features and body mineral density in Italian patients with rapid onset obesity with hypoventilation, hypothalamic dysfunction, autonomic disregulation and neural tumor (ROHHADNET): a single center observational study
hrp0094p1-159
Congenital Central Hypothyroidism (CeH) due to a new variant in IGSF1 gene: clinical case of 2 siblings
hrp0094p1-160
Growth B
Continued Safety and Efficacy of Weekly Lonapegsomatropin (TransCon hGH) for up to Two Years in Children with Growth Hormone Deficiency (GHD)
hrp0094p1-161
Evaluation of growth patterns from the Edinburgh and Gothenburg cohorts by the QEPS model
hrp0094p1-162
The etiology of extreme tall stature above +3 SDS in a screened Finnish population
hrp0094p1-163
Long-term efficacy and safety of rhGH in children with SHOX deficiency: preliminary data of a national Italian survey (on behalf of ISPED Study Group on Growth Factors and Puberty).
hrp0094p1-164
Effects of age of start growth hormone treatment in children with Prader-Willi syndrome: The earlier the better?
hrp0094p1-165
The BoneXpert adult height prediction method outperforms the Bayley and Pinneau method in tall male adolescents.
hrp0094p1-166
Sex differences in growth response to GH treatment: more prepubertal and less pubertal gain in girls diagnosed with IGHD, ISS, SGA. Analysis of data from GH-SAFETY-database, including all children treated with rhGH- 1986-2009 in Sweden, in National-GH-Registry and rhGH-clinical-trials.
hrp0094p1-167
Mother’s smoking during pregnancy influence intrauterine and postnatal growth - the GrowUp 1990 Gothenburg cohort population
hrp0094p1-168
Safety of growth hormone and cardiovascular outcomes in patients with Noonan syndrome enrolled in NordiNet® International Outcome Study (IOS) and the ANSWER Program
hrp0094p1-169
Facilitating Telehealth In A Tertiary Paediatric Endocrine Service: A Quality Improvement Initiative To Reduce The Discrepancy Between Parent-reported And Auxologist Height Measurements
hrp0094p1-170
Growth Hormone and IGFs B
Diagnosing growth hormone deficiency - Can a combined arginine and clonidine stimulation test replace two separate tests?
hrp0094p1-171
Glucagon Testing of Childhood-Onset Growth Hormone Deficiency during Transition
hrp0094p1-172
Growth hormone receptor 6Ω pseudoexon activation: a novel cause of severe growth hormone insensitivity
hrp0094p1-173
High incidence and male predominance of transient form of isolated growth hormone (GH) deficiency in children. What is the optimal time for GH therapy withdrawal and retesting?
hrp0094p1-174
Growth without growth hormone. A tertiary care hospital’s experience
hrp0094p1-175
Irisin in the growth hormone deficient children: before and on rhGH therapy.
hrp0094p1-176
Immunogenicity of recombinant growth hormone and relationship its growth-promoting effect in the children with short stature
hrp0094p1-177
Study on linear growth of children with idiopathic short children (ISS) with Low Insulin-like growth factor 1 (IGFI) at diagnosis: Growth hormone (GH) treatment versus no treatment.
hrp0094p1-178
Novel dominant negative GH receptor variants provide important insights into GH receptor physiology
hrp0094p1-179
The miRNA network and the interplay between growth and cancer regulating pathways in prepubertal patients with idiopathic isolated growth hormone deficiency (IGHD) on growth hormone (GH) treatment
hrp0094p1-180
Pituitary B
Continuous versus discontinuous administration of gonadotropin in neonates with congenital hypogonadotropic hypogonadism
hrp0094p1-181
Sequence of MKRN3 and DLK1 genes in cases with familial central precocious puberty
hrp0094p1-182
Hypoandrogenism degree and lipid profile in boys with delayed puberty
hrp0094p1-183
The pituitary gonadal axis is not responsive to GnRH administration in PCSK 1 dysfunction
hrp0094p1-184
Puberty and pituitary-gonadal axis function after treatment for a childhood brain tumor
hrp0094p1-185
Additive effect of androgens and estrogens on pubertal growth acceleration
hrp0094p1-186
The Adrenal Steroid Profile in Adolescent Depression: A Valuable Bio-Readout?
hrp0094p1-187
Congenital hypogonadotropic hypogonadism in a large French cohort : New genetic findings
hrp0094p1-188
Dimensional changes in structures of craniofacial and brain in precocious puberty: Developmental surrogate markers of the brain as a secondary sex characteristic in puberty
hrp0094p1-189
Six novel variants in the MKRN3 gene causing central precocious puberty: characteristics of ten patients and their affected relatives
hrp0094p1-190
Thyroid B
The Impact of Hospital Surgical Volume on Healthcare Utilisation Outcomes after Paediatric Thyroidectomy
hrp0094p1-191
Analysis of hypothyroidism NGS test in Korean patients with congenital hypothyroidism in a single center
hrp0094p1-192
Further evidence that Borealin/CDCA8 is involved in thyroid morphogenesis and aging
hrp0094p1-193
Role of Next Generation Sequencing in the etiological diagnosis of congenital hypothyroidism with gland in situ
hrp0094p1-194
DNA Methylation at a nutritionally sensitive region of the PAX8 gene is associated with thyroid volume and function in Gambian children
hrp0094p1-195
Clinical and Molecular Presentation of Congenital Hypothyroidism Caused by Thyroglobulin Gene Mutations
hrp0094p1-196
Management of newborns born to mothers with autoimmune hypothyroidism
hrp0094p1-197
Novel single nucleotide variation in DUOX2 and NPTX1 genes in two Sardinian sisters with transient congenital hypothyroidism
hrp0094p1-198
New p.Ser237Asn Activating Mutation At The TSHR Receptor, Causing Familial Non- Autoimmune Hyperthyroidism
hrp0094p1-199
Functional studies of
PAX8
gene variants in patients affected by congenital hypothyroidism with eutopic thyroid gland
hrp0094p1-200
ePoster Category 2
Adrenals and HPA Axis
Circadian rhythm of salivary cortisol and cortisone in school-aged children born very preterm and adequate for gestational age
hrp0094p2-1
How do urine steroid metabolites of spot samples correlate with 24 hour urine specimens in children with congenital adrenal hyperplasia?
hrp0094p2-2
Endocrine-disrupting chemicals: an often-forgotten etiology of endocrinological disturbances
hrp0094p2-3
Serum Sex Hormone Binding Globulin Levels, But Not 4-Hour Profile of 17-Oh Progesterone, Would Be Useful in Monitoring Children with Congenital Adrenal Hyperplasia
hrp0094p2-4
Glucocorticoid side-effects in Duchenne Muscular Dystrophy: Systematic review of side effects in published literature and a survey of the concerns of the patient community
hrp0094p2-5
Single centre experience of Hydrocortisone Granules (Alkindi) in children under 6 years of age with Adrenal Insufficiency
hrp0094p2-6
Emotion regulation in congenital adrenal hyperplasia
hrp0094p2-7
High-dose steroids in the management of Paediatric Multisystem Inflammatory Syndrome Temporally associated with SARS-CoV-2 (PIMS-TS): Considering the hypothalamic-pituitary-adrenal axis
hrp0094p2-8
Variability of advice and education for steroid sick day dosing in Duchenne Muscular Dystrophy and the impact of the COVID-19 pandemic: Results of a UK wide patient survey
hrp0094p2-9
Clinical characteristics of cytochrome P450 oxidoreductase deficiency: a nationwide survey in Japan
hrp0094p2-10
Rare Presentation of Adrenal Insufficiency in an Infant with Holocarboxylase Synthetase Deficiency
hrp0094p2-11
Defective Cortisol Secretion in Response to Spontaneous Hypoglycemia but Normal Cortisol Response to ACTH stimulation in neonates with Hyperinsulinemic Hypoglycemia (HH).
hrp0094p2-12
Utilisation Of The I-CAH Registry As A Tool For Facilitating Health Quality Improvement Strategies- Results Of An International Survey Of Specialist Centres
hrp0094p2-13
Clinical and hormonal evolution of aldosterone synthase deficiency: Is complete remission possible?
hrp0094p2-14
Clinical and metabolic characteristics of hyperandrogenic girls with non-classic congenital adrenal hyperplasia and polycystic ovary syndrome
hrp0094p2-15
Rapid clearance of hydrocortisone as a cause of poor control of CAH detected by 24-hour profiling of hydrocortisone concentrations.
hrp0094p2-16
A prospective study of children 0-8 years with congenital adrenal hyperplasia and adrenal insufficiency on treatment with hydrocortisone granules monitored by 17-OHP saliva sampling
hrp0094p2-17
Cushing’s disease treatment results correlation with pituitary MRI in children
hrp0094p2-18
Genetic analysis of paediatric primary adrenal insufficiency of unknown aetiology over 25 years
hrp0094p2-19
Panhypopituitarism after treatment procedures in pituitary-hypothalamic area - a single center experience
hrp0094p2-20
The reliability of Salivary Cortisol compared to Serum Cortisol for diagnosing adrenal insufficiency in the gold standard ACTH stimulation test in children
hrp0094p2-21
Prevalence of adrenal insufficiency (AI) requiring treatment with hydrocortisone in children tested with the LDSST
hrp0094p2-22
Serum cortisol and cortisone, and urinary cortisol, cortisone, and tetrahydro-metabolites concentrations in school-aged children born very preterm adequate for gestational age
hrp0094p2-23
The incidence and presentation of congenital adrenal hyperplasia in an unscreened population
hrp0094p2-24
Genotypic Sex and Severity of the Disease Determine the Time of Clinical Presentation in Steroid 17[alpha]-Hydroxylase/17,20-Lyase Deficiency
hrp0094p2-25
Testicular adrenal rest tumour in children with classical congenital adrenal hyperplasia: A case series.
hrp0094p2-26
High doses op’-DDD cause metrorragia in young girls
hrp0094p2-27
An Adolescent Case With Adrenoleukodystrophy Diagnosed After Detection Of Leydig Cell Dysfunction
hrp0094p2-28
Fludrocortisone is the salvage treatment in cases with calcineurin inhibitor related hyperkalemia
hrp0094p2-29
Development of a novel weight-based steroid emergency plan for patients with Duchenne Muscular Dystrophy
hrp0094p2-30
Investigation of usage and acceptance of hydrocortisone granules in capsules for opening in children with adrenal insufficiency
hrp0094p2-31
Congenital Adrenal Hyperplasia caused by homozygous pathogenic variant in the HSD3B2 gene.
hrp0094p2-32
Congenital Adrenal Hyperplasia with a
CYP21A2
deletion overlapping Tenascin-X gene
hrp0094p2-33
Maternal primary adrenal cortex insufficiency during pregnancy: Spotlight on the Fetus and the Neonate. A systematic review and meta-analysis.
hrp0094p2-34
Assessment of blood pressure and carotid intima media thickness (CIMT) in children with primary adrenal insufficiency
hrp0094p2-35
Challenging in diagnosis and treatment of Cushing Disease in a 12 years old boy
hrp0094p2-36
Congenital Adrenal Hyperplasia caused by compound heterozygosity of two novel CYP11B1gene variants.
hrp0094p2-37
Addison’s disease: Delay in diagnosis in a girl with longstanding symptoms
hrp0094p2-38
Clinical spectrum of congenital adrenal hyperplasia due to 3 beta hydroxysteroid dehydrogenase deficiency; A case series
hrp0094p2-39
Retrospective Evaluation of Cases Diagnosed with Classical Congenital Adrenal Hyperplasia Due to 21 Hydroxylase Deficiency
hrp0094p2-40
Corticotropin-independent Cushing’s Syndrome in toddlerhood: a challenging diagnosis and treatment
hrp0094p2-41
A case of adrenal insufficiency during the course of multisystem inflammatory syndrome in children (MIS-C)
hrp0094p2-42
Aetiology and different clinical conditions of primary adrenal insuffiency in a region of North Africa
hrp0094p2-43
Clinical and evolutionary aspects of Allgrove Syndrome, Algerian experience
hrp0094p2-44
A Rare Coexistence of two autosomal recessive conditions: Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency (CYP21A2 mutation) with Beta Thalassemia Major
hrp0094p2-45
X-linked Adrenoleukodystrophy in south of Tunisia
hrp0094p2-46
Clinical, biological and genetic aspects of congenital adrenal hyperplasia in children at the Central Army Hospital in Algiers
hrp0094p2-47
Coexistence of Adrenal Insufficiency and Hypergonadotropic Hypogonadism: P450scc Deficiency
hrp0094p2-48
Assessment of Patients With Congenital Adrenal Hyperplasia in Armenia
hrp0094p2-49
First case in Lebanon of homozygous mutation in CYP 11B2 leading to isolated aldosterone deficiency.
hrp0094p2-50
A Rare Cause of Hyponatremia in a Child with Hirschsprung Disease Operated with an Ileostomy
hrp0094p2-51
Adrenal insufficiency masquerading as biliary atresia in an infant
hrp0094p2-52
Mutation of NROB1 and Double mutants in cis of CYP21A2 gene in a Chinese boy with primary adrenal insufficiency
hrp0094p2-53
Clinical and hormonal features of the manifestation of various forms of congenital adrenal hyperplasia in children in real clinical practice
hrp0094p2-54
Twin infants with salt-wasting: double the trouble
hrp0094p2-55
Effect of treatment of double precocious puberty in a 9-year-old girl- case report
hrp0094p2-56
Classical Congenital adrenal hyperplasia: about 7 cases
hrp0094p2-57
Bone, growth plate and mineral metabolism
Denosumab therapy for giant cell granuloma in a paediatric patient: using quantification of Tc99m-MDP uptake on SPECT imaging to guide treatment.
hrp0094p2-58
Vertebral compression and shape in children with osteogenesis imperfecta on regular Zoledronic acid infusions
hrp0094p2-59
Osteosclerotic Metaphyseal Dysplasia: A novel homozygous LRRK1 mutation in two siblings
hrp0094p2-60
Experience of 6-months of burosumab therapy in five siblings with X-linked hypophosphataemic rickets in the State of Kuwait
hrp0094p2-61
Severe Hypophosphatemic Rickets due to Tumor-Induced Osteomalasia
hrp0094p2-62
Diagnostic Challenges of Vitamin D-Dependent Rickets Type 1A (VDDR1A) caused by CYP27B1 mutation in Resource Limited Countries: A Case Series from Three families
hrp0094p2-63
Lack of Cinacalcet response in Neonatal Severe Hyperparathyroidism (NSHPT) due to homozygous CASR mutation
hrp0094p2-64
Is conventional treatment still the first choice in pediatric patients with PHEX mutations in an era of monoclonal FGF-23 antibody?
hrp0094p2-65
Vosoritide Clinical Study Data Demonstrates CXM is a Superior Biomarker of Endochondral Bone Growth
hrp0094p2-66
X-linked hypophosphatemic rickets caused by a large deletion in PHEX gene in a Brazilian family
hrp0094p2-67
Mutational analysis and genotype-phenotype correlation of the PHEX gene in Brazilian patients with X-linked hypophosphatemic rickets
hrp0094p2-68
Evaluation of Admission Characteristics, Treatment and Follow-up Findings of Children with Primary Osteoporosis
hrp0094p2-69
Phenotype characterization of a PHEX intron mutation in an Italian family affected by X linked hypoposphatemic rickets.
hrp0094p2-70
Premature epiphyseal fusion induced by Palovarotene in a young girl with fibrodysplasia ossificans progressiva
hrp0094p2-71
ACAN gene skeletal dysplasia (short size syndrome, with or without advanced bone age and early onset osteoarthritis)
hrp0094p2-72
PTEN downregulation in mouse osteoprogenitor cells impacts on bone stability and turnover
hrp0094p2-73
Primary hyperparathyroidism due to a deletion of the CDC73 gene.
hrp0094p2-74
Afebrile seizure in a toddler girl with alopecia: a case report
hrp0094p2-75
A rare cause of hypophosphatemic rickets; Non-lethal Raine syndrome
hrp0094p2-76
Effect of tamoxifen on linear growth of precocious female SD rats
hrp0094p2-77
Deleting STX16 exon 4 to understand the genetic mechanisms underlying pseudohypoparathyroidism-1B and GNAS imprinting
hrp0094p2-78
Clinical, molecular characterization and long-term follow-up of a patient with neonatal severe hyperparathyroidism
hrp0094p2-79
Effect of Soy and Whey on growth pattern in young male Sprague-Dawley rats
hrp0094p2-80
Early-onset osteoporosis due to LRP5
hrp0094p2-81
Vitamin D - What is the Optimal Level in the Pediatric Population
hrp0094p2-82
Schimke immune-osseous dysplasia manifested by stunted growth and spinal epiphyseal dysplasia: a case report
hrp0094p2-83
A rare cause of childhood hypercalcemia: Parathyroid adenoma
hrp0094p2-84
One gene, two diseases: osteogenesis imperfecta, or Bruck syndrome?
hrp0094p2-85
Spontaneous Reshaping of Vertebral Fractures in an Adolescent with Osteogenesis Imperfecta
hrp0094p2-86
A rare presentation of Dysplasia Epiphysealis Hemimelica combined with Familial Hypocalciuric Hypercalcemia - Is this association possible?
hrp0094p2-87
Two sibling cases with heterozygous calcium sensing receptor (CaSR) gene mutation
hrp0094p2-88
Clinical Profile of Parathyroid Adenoma in Children and Adolescents: A single-center experience
hrp0094p2-89
Changing reality: rebirth of old diseases in new circumstances. Severe vitamin D deficiency presenting as hypocalcemic seizures in a healthy adolescent after prolonged COVID-19 lock-down.
hrp0094p2-90
Two-year experience of burosumab therapy in pediatric XLH patients in Saudi Arabia
hrp0094p2-91
Pseudohypoparathyroidism with hypokalemia and hypomagnesemia: association or separate entity?
hrp0094p2-92
Characterization of Patients with Achondroplasia in a pediatric clinic of Cali, Colombia.
hrp0094p2-93
A Rare Cause of Familial Hypomagnesemia: A Case with Trpm6 Mutation
hrp0094p2-94
Effect of cholecalciferol treatment on serum FGF-23, vitamin D-binding globulin and [alpha]-klotho levels in children with vitamin D deficiency
hrp0094p2-95
HDR Syndrome (Barakat Syndrome): Case Report
hrp0094p2-96
Hungry Bone Syndrome associated to Rickets
hrp0094p2-97
BUR-CL207: An Open-label, Multicenter, Non-randomized Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Burosumab in Pediatric Patients from Birth to Less than 1 Year of Age with XLH.
hrp0094p2-98
Diabetes and insulin
Glycemic Dysregulation During Treatment Of Childhood Hematologic Malignancies.
hrp0094p2-99
The knowledge and Confidence in Management of Diabetic Ketoacidosis (DKA) among Iraqi Paediatric Residents: a Cross Sectional Study
hrp0094p2-100
Disturbances of glucose homeostasis in polytransfused beta-thalassemia patients
hrp0094p2-101
Unmet need in technology for diabetes management in the Middle East, Africa and South East Asia
hrp0094p2-102
Diabetes in a child with infantile onset multisystem neurological, endocrine and pancreatic disease (IMNEPD)
hrp0094p2-103
The clinical characteristics of hybrid diabetes (HD) in children and their response to treatment.
hrp0094p2-104
Recurrent episodes of hypoglycemia in an infant with type 1 spinal muscular atrophy after gene therapy: Beta oxidation defect exaggerated by hepatic dysfunction.
hrp0094p2-105
Knowledge of the Final Year Medical Students Compared to Interns about the Diagnosis and management of Diabetes Mellitus
hrp0094p2-106
A paradoxical conundrum: diabetic ketoacidosis resulting in treatment-resistant hypokalemic alkalosis
hrp0094p2-107
Impact of the COVID19 pandemic on Paediatric Diabetes Services in Arab Countries
hrp0094p2-108
Clinical Case of Cystic Fibrosis-like and APECED-like Syndrome due to Gain-of-Function Variant in STAT1
hrp0094p2-109
A quality improvement project of a Young Adult Diabetes (YAD) service at a UK specialist centre.
hrp0094p2-110
Prevalence of skin reactions among pediatrics patients with Type 1 Diabetes users of glucose sensors.
hrp0094p2-111
A single-centre evaluation of remote video consultation for children and young people with diabetes
hrp0094p2-112
Health Outcome Indicators in Children with Diabetes Mellitus during the SARS-CoV-2 Pandemic
hrp0094p2-113
Evaluation of serum myostatin levels in patients with insulin dependent diabetes mellitus
hrp0094p2-114
HbA1c and Glucose Management Indicator relationship: can HbA1c determination be avoided?
hrp0094p2-115
Sex differences over two decades for glycaemic control, pump use and insulin dose in patients aged 10-20 years with type 1 diabetes
hrp0094p2-116
Cardiovascular risk factors in adolescents with type 1 diabetes: Prevalence and gender differences
hrp0094p2-117
Bilateral severe proliferative retinopathy, macular oedema, and lack of macrocytosis in an adolescent male with thiamine-responsive megaloblastic anaemia
hrp0094p2-118
First Survey About Pediatric Diabetes Services in Iraq
hrp0094p2-119
Effect of metabolic control on the presence of Nonalcoholic Fatty Liver Disease (NAFLD) in adolescents with type 2 Diabetes.
hrp0094p2-120
The effect of glycemic variability on DNA damage in pediatric patients with type 1 Diabetes Mellitus
hrp0094p2-121
Parental insulin resistance is associated with unhealthy lifestyle behaviours independently of body mass index in children: The Feel4Diabetes study
hrp0094p2-122
Use of the whole country insulin consumption data in Israel showed a reduced prevalence of type 1 diabetes in children aged <5 years during universal Rotavirus vaccination
hrp0094p2-123
Psychological changes in youth with diabetes: comparison between preadolescents and adolescents
hrp0094p2-124
Focal Congenital Hyperinsulinism in Infancy is Directly Linked to Increased Numbers of Islet Pancreatic Polypeptide Cells in Islets.
hrp0094p2-125
Oral administration of CRN04777, a nonpeptide selective SST5 receptor agonist, suppresses insulin secretion and rescues hypoglycemia in neonatal rat models of congenital hyperinsulinism
hrp0094p2-126
Thiamine-responsive megaloblastic anemia: a rare presentation of an uncommon disease!
hrp0094p2-127
Daily Meal Size Variation Does Not Affect Glycemic Control In T1D Adolescent Patients Equipped With The Closed Loop DBLG1 System
hrp0094p2-128
Evaluation of continuous glucose monitoring for the diagnosis of cystic fibrosis related diabetes (CFRD). A prospective and longitudinal study
hrp0094p2-129
Blood lipid concentrations of newborns and their mothers with gestational diabetes
hrp0094p2-130
Comparison between hybrid diabetes (HD) and type 2 diabetes (T2DM) in children; Patient`s characteristics at diagnosis: a retrospective observational study.
hrp0094p2-131
Features of the manifestation of type 1 diabetes in children in COVID-19 pandemic
hrp0094p2-132
Risk factors of autoimmune thyroid disease in children with type 1 diabetes mellitus
hrp0094p2-133
Does SARS-COV-2 outbreak increase diabetic ketoacidosis in new onset T1DM
hrp0094p2-134
Heterozygous mutation in the PAX4 gene: a first case description of MODY9 in Vietnam
hrp0094p2-135
Evaluation of the Effect of Carbohydrate Count on Nutritional Habits and Metabolic Control in Adolescents with Type 1 Diabetes
hrp0094p2-136
Nutritional evaluation of children with type 1 diabetes on admission to the Endocrinology-Diabetology and Nutrition Department
hrp0094p2-137
Correlation between antiinsulin autoantibodies and clinical presentation in T1DM
hrp0094p2-138
Different schemes of insulin therapy (CSII and MDII) in children with DM1 in a Dnipro city.
hrp0094p2-139
HbA1c of T1DM Patients before and after Transition - Single Center Experience
hrp0094p2-140
Glycated Hemoglobin Variability and Microvascular Complications in Patients with Type 1 Diabetes Mellitus
hrp0094p2-141
Affective response of newly diagnosed Type1 diabetes parents: An experience of a developing country.
hrp0094p2-142
Short-term glycaemic changes from continuous glucose monitoring among children and adolescents with type 1 diabetes mellitus during fasting in Ramadan month
hrp0094p2-143
Is Type 1 Diabetes Mellitus Predictable? Investigation of Predictive Markers n Siblings of Probands with Newly Diagnosed Type 1 Diabetes Mellitus
hrp0094p2-144
Dealing with hypoglycaemia during acute DKA management by paediatric residents from Bahrain, Iraq and Saudi Arabia
hrp0094p2-145
A Rare Clinical Case Of A Combination Of Monogenic And Autoimmune Diabetes Mellitus.
hrp0094p2-146
Thrombocytopaenia induced by diazoxide treatment in a toddler with Hyperinsulinism-Hyperammonemia syndrome: a rare side-effect
hrp0094p2-147
Nephrotic Syndrome and Type 1 Diabetes: a Therapeutic Approach
hrp0094p2-148
Assessment of the percentage of T lymphocytes and B lymphocytes with the expression of selected activation markers in patients with type 1 diabetes mellitus depending on the presence of antibodies against EBV antigens.
hrp0094p2-149
PIMS-TS [Paediatric Inflammatory Multisystem Syndrome Temporally associated with SARS-CoV-2 (Covid-19)] in a child with new onset type 2 diabetes
hrp0094p2-150
The impact of COVID-19 lockdown on glycaemic control and BMI in children with type 1 diabetes mellitus (T1DM)
hrp0094p2-151
Timing of Consulting Paediatric Endocrinologist or Diabetologist During the Management of Acute DKA; Response of Bahraini, Iraqi, and Saudi Paediatric Residents
hrp0094p2-152
Prevalence and factors associated with microalbuminuria in type 1 diabetic children and adolescents on follow up at Pediatric Endocrinology Clinic in Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia
hrp0094p2-153
Neonatal Diabetes Secondary to Isolated Pancreatic Agenesis
hrp0094p2-154
Dyslipidaemia in children with type 1 diabetes mellitus
hrp0094p2-155
The relationship between metabolic parameters atherogenic parameters, atherogenic index and vitamin D levels in children with insulin-dependent diabetes mellitus
hrp0094p2-156
A case of severe hypertriglyceridaemia complicating new-onset type 1 diabetes mellitus
hrp0094p2-157
A novel variant HNF1A gene (HNF1A-MODY) in a patient presenting with hyperglycaemia and glycosuria
hrp0094p2-158
Glucose 6 phosphate dehydrogenase deficiency diagnosed with hemolytic anemia triggered by diabetes mellitus type 1
hrp0094p2-159
HbA1C stability - is posting samples reliable?
hrp0094p2-160
Not every obese child has type 2 Diabetes Mellitus
hrp0094p2-161
Does insulin pump therapy improve glycaemic control in type 1 diabetes children: one year follow up
hrp0094p2-162
Mauriac syndrome: a complication that still exists in children with type 1 diabetes. Report of a case.
hrp0094p2-163
The Impact of COVID 19 Pandemic on Type 1 Diabetes Mellitus: An experience of a Tertiary Care Hospital in a resource limited country
hrp0094p2-164
Co-existence of new onset diabetic ketoacidosis with severe hypertriglyceridemia in a 9 year old girl.
hrp0094p2-165
How Does Continuous Glucose Monitoring Systems Effect Metabolic Control In Type 1 Diabetes: Single Center Experience
hrp0094p2-166
Blood level of Vitamin D and metabolic control of type 1 diabetes mellitus
hrp0094p2-167
Newly-onset type 1 diabetes mellitus triggered by COVID-19: Original case report
hrp0094p2-168
Case of HNF1B MODY
hrp0094p2-169
Diabetes Ketoacidosis Recovery in Youth with Newly Diagnosed and Established Type 1 Diabetes
hrp0094p2-170
Fat, metabolism and obesity
Association of calprotectin with obesity in prepubertal children
hrp0094p2-171
Metabolic syndrome and birth anthropometric data in Prader-Willi syndrome.
hrp0094p2-172
Evaluation of the BigO system during the COVID-19 outbreak in Greece
hrp0094p2-173
The relationship between sleep time and obesity in childhood
hrp0094p2-174
The relationship between acanthosis nigricans and vitamin D in obese children and adolescents
hrp0094p2-175
Exploring Urinary Bile Acids as Potential Markers of Metabolism: Reference Values in Children by Targeted LC-MS/MS
hrp0094p2-176
A novel mitochondrial tRNA
Thr
15894G>A mutation is potentially risk factor in a Chinese family with obesity
hrp0094p2-177
Obesity is potentially associated with a novel mitochondrial tRNA
Gly
10029A>G mutation in a Chinese family
hrp0094p2-178
Frequency of MC4R Pathway Variants in a Large US Cohort of Pediatric and Adult Patients with Severe Obesity
hrp0094p2-179
Impact of the COVID-19 pandemic and related lockdown measures on lifestyle behaviours and quality of life in children and adolescents with severe obesity
hrp0094p2-180
Longitudinal association of the anti-inflammatory serum marker GDF-15 with serum IgA and IgG in apparently healthy children
hrp0094p2-181
Describing the Natural History of Clinical, Biochemical and Radiological outcomes of children with Familial Partial Lipodystrophy type 2 (FPLD2) attending a National Service for Severe Insulin Resistance: a Retrospective Cohort Study
hrp0094p2-182
Evaluation of the BigO system in a clinical setting in Greece
hrp0094p2-183
Assessment of DRD2 dopamine receptor gene rs6277 in pediatric obesity: a case-control study
hrp0094p2-184
A Comprehensive, Multidisciplinary, Personalized, Lifestyle Intervention Program is Associated with Increased Leukocyte Telomere Length in Children and Adolescents with Overweight and Obesity
hrp0094p2-185
Diagnostic accuracy of Tri-Ponderal mass index (kg/m
3
) for identifying glucose intolerance in obese children and adolescents.
hrp0094p2-186
Effect of Semaglutide on body weight in obese children with craniopharyngioma: a preliminary report
hrp0094p2-187
Development of a predictive normogram to assess the risk of liver steatosis in childhood obesity
hrp0094p2-188
Prospective evaluation of liver stiffness in obese children: the role of shear wave elastography.
hrp0094p2-189
Evaluation of the nutritional behavior of small and large for gestational age children
hrp0094p2-190
Resting energy expenditure and body composition in children and adolescents with severe obesity due to (suspected) medical causes: comparison between different subtypes of obesity
hrp0094p2-191
Exercise-induced expression of myokines in adolescents with simple obesity.
hrp0094p2-192
Early decline in Sertoli cell function during puberty in overweight and obese boys: a cross-sectional study
hrp0094p2-193
Vitamin D deficiency in obese children
hrp0094p2-194
Assessment of Hyperphagia in Patients with Monogenic Obesity
hrp0094p2-195
Machine Learning Quest for Predictive Markers of Lifestyle Modification Outcomes in Pediatric Obesity Treatment
hrp0094p2-196
Triponderal mass index for the categorisation of childhood obesity on the basis of 58.364 observations of 7.792 patients
hrp0094p2-197
Successful weight loss and resolution of hepatic fibrosis in a girl with severe obesity
hrp0094p2-198
Association of Thyroid-Stimulating Hormone and Free Thyroxine Concentrations with Cardiometabolic Risk Factors in Euthyroid Obese Children and Adolescents with Metabolic Syndrome
hrp0094p2-199
Impact of weight loss on gonadic function in overweight and obese boys
hrp0094p2-200
Weight status and body composition of children and adolescents during the COVID-19 pandemic
hrp0094p2-201
The challenges faced in the management of Congenital Generalized Lipodystrophy.
hrp0094p2-202
Anthropometric and clinical situation in two groups of young adults born Small for Gestational Age (a group with catch-up and another without catch-up and treated with Growth Hormone)
hrp0094p2-203
Changes in objectively measured physical activity after 2-year lifestyle intervention in pediatric patients with abdominal obesity
hrp0094p2-204
Assessment of cardiometabolic risk factor clustering in obese children and adolescents with metabolic syndrome
hrp0094p2-205
HOMA-IR in obese children with BMI ≥2.5SDS, but not <2.5SDS, differ significantly from normal weight children
hrp0094p2-206
Restriction of physical activity is the main cause of childhood obesity during the COVID-19 pandemic - reflections from a study conducted in 3 clinical centers in southern Poland
hrp0094p2-207
OSAS in childhood obesity is a more frequent and earlier complication than expected
hrp0094p2-208
A novel homozygous variant of the leptin receptor (LEPR) gene causing familiar early-onset severe obesity in two siblings
hrp0094p2-209
Sleep quality and metabolic syndrome in pediatric patients with abdominal obesity
hrp0094p2-210
The lockdown effects on a pediatric obese population in the COVID-19 era
hrp0094p2-211
The Relationship between Acanthosis Nigricans and Vitamin D Levels in Obese Children
hrp0094p2-212
Influence of birth weight on cardiovascular risk factors in obese children and adolescents
hrp0094p2-213
A study on the Complications associated with Severe Obesity in Children and Young People
hrp0094p2-214
The Effectiveness of Indigenous Knowledge-Based Lifestyle Interventions in Preventing Obesity and Type 2 Diabetes Mellitus in Indigenous Children in Canada
hrp0094p2-215
The effects of dextroamphetamine treatment in children with hypothalamic obesity
hrp0094p2-216
Nutritional status in premature infants born small by gestational age in the first 5 years of life
hrp0094p2-217
Impact of overweight and obesity in pediatrics. Metabolic syndrome and its components
hrp0094p2-218
What do lipids tell us about the pandemic?
hrp0094p2-219
Characteristics of eating behavior in children with type 1 diabetes and obesity
hrp0094p2-220
[ldquo]Sleep Properly, Reduce Intake, aNd Get Stepping[rdquo] (SPRINGS): a multidisciplinary approach to managing paediatric morbid obesity with severe obstructive sleep apnoea
hrp0094p2-221
Design of a Phase 2, Double-Blind, Placebo-Controlled Trial of Setmelanotide in Patients With Genetic Variants in the Melanocortin-4 Receptor Pathway
hrp0094p2-222
Absence of dyslipidemia in obese children with BMI ≥2.5SDS and similar lipidemic profile to those with BMI <2.5SDS or normal weight
hrp0094p2-223
Inflammation associated to body composition in European prepubertal children: Results from the IDEFICS study
hrp0094p2-224
A case report of sitosterolemia and the early differential diagnosis
hrp0094p2-225
Thyroid function in youth with metabolic syndrome
hrp0094p2-226
Global survey study of awareness, care and treatment of adolescents living with obesity, their caregivers and healthcare professionals: ACTION Teens
hrp0094p2-227
Lifestyle habits, consumption of non-nutritive sweeteners and obesity in students and young adults’ population in Latvia.
hrp0094p2-228
Influence of the basal metabolic profile on the evolution of the pediatric patient with obesity
hrp0094p2-229
Fetal, neonatal endocrinology and metabolism (to include hypoglycaemia)
The utility of continuous glucose monitoring systems in the management of children with persistent hypoglycaemia
hrp0094p2-230
Hyperinsulinaemic hypoglycaemia as a MEHMO syndrome component: a case report
hrp0094p2-231
Methylation of umbilical cord genes associates with gestational weight gain and offspring’s cardio-metabolic profile
hrp0094p2-232
Diazoxide Responsive Congenital Hyperinsulinism
hrp0094p2-233
Continuous Glucose Monitoring (CGM) Reveals Undertreated Hypoglycemia in Patients with Congenital Hyperinsulinism
hrp0094p2-234
A Selective Nonpeptide Somatostatin Receptor 5 (SST5) Agonist Effectively Decreases Insulin Secretion in a KATPHI Mouse Model and in Human HI Islets
hrp0094p2-235
Placental
FRAT-1
methylation in women with gestational obesity is associated with the body composition in the offspring at 6 years of age
hrp0094p2-236
Placenta n-6/n-3 PUFA ratio is associated with visceral adiposity and cardiovascular risk in the offspring at 6 years of age
hrp0094p2-237
Analysis of Placental Steroidogenesis as a Cause of Recurrent Miscarriage
hrp0094p2-238
Antenatal Markers Related to Fetal Growth Restriction Can Predict Childhood Systolic Blood Pressure
hrp0094p2-239
Hypomethylation of the Prader-Willi imprinting control region associates with postnatal growth and visceral adiposity in healthy children
hrp0094p2-240
Incidence of early neonatal hypoglycemia and some related risk factors in Qatar. A cohort study over two years (2018 and 2019)
hrp0094p2-241
Long-term follow-up in a case with congenital hyperinsulinemic hypoglycemia with a novel p.Ser1389Pro mutation in ABCC8 gene
hrp0094p2-242
Postnatal linear growth and weight gain in infants of non-diabetic mothers (INDM) who were born preterm or near term and had significant neonatal hypoglycemia.
hrp0094p2-243
Genetic Testing Access and Results for Patients with Congenital Hyperinsulinism as Conducted through the CHI and University of Exeter Partnership
hrp0094p2-244
Predictors of short stature in intrauterine growth retardation in a region of north Africa
hrp0094p2-245
Growth hormone and IGFs
Massive Open Online Learning - accelerating knowledge in digital health in the management of children with growth disorders
hrp0094p2-246
A girl with concurrent congenital adrenal hyperplasia, isolated growth hormone deficiency type II (IGHD II) and a new mutation in the GH 1 gene - an extremely unusual case
hrp0094p2-247
Reduction in pappalysin and stanniocalcin levels explain the decrease in IGF-I bioavailability in anorexia nervosa
hrp0094p2-248
Predictors of short stature in premature infants born small for gestational age
hrp0094p2-249
Patterns of suboptimal adherence to growth hormone treatment in children living in Italy
hrp0094p2-250
Screening of celiac disease among children with growth hormone deficiency and idiopathic short stature
hrp0094p2-251
Pappalysins and stanniocalcins in prenatal and postnatal life
hrp0094p2-252
GROWPATI Study: Growth and puberty description pattern in a well-characterized cohort of patients with growth retardation due to severe primary IGF1 deficiency
hrp0094p2-253
Clinic, laboratory and prognostic findings of patients who are diagnosed by Kowarski syndrome (biologically inactive growth hormone)
hrp0094p2-254
Prevalence of insulin-like growth factor 1 (IGF1) deficiency in prepubertal children with isolated short stature (ISS) and their response to GH therapy.
hrp0094p2-255
Thyroid function (TF) in short children with idiopathic short stature (ISS) treated with growth hormone (GH)versus those not treated; a controlled study.
hrp0094p2-256
Investigating the impact of the TuiTek patient support programme, designed to support caregivers of children prescribed recombinant human growth hormone treatment for growth hormone deficiency in Taiwan: A pilot study
hrp0094p2-257
Incidence of ALS deficiency in patients with growth hormone deficiency at tertiary pediatric endocrinology center
hrp0094p2-258
Presentation of IGF-1/IGFBP-3 molar ratio as an effective monitoring index during treatment of growth hormone deficient patients
hrp0094p2-259
Current growth hormone therapy practices in Belgium for the treatment of short children born small for gestational age
hrp0094p2-260
Increased height and IGF1 serum levels in children with non-neurofibromatosis type 1 gliomas
hrp0094p2-261
A Survey on Clinician Perceptions of Long-Acting Growth Hormone Analogs
hrp0094p2-262
Pituitary gland volume measured by Magnetic Resonance Imaging as diagnostic predictor of persistent Childhood-onset growth hormone deficiency
hrp0094p2-263
Growth hormone (GH) treatment of children with idiopathic short children (ISS) with normal insulin-like growth factor-1 (IGF-1) versus those with low IGF-I at diagnosis.
hrp0094p2-264
Growth response to growth hormone therapy in growth hormone deficient (GHD) children in relation to the distance between their height SDS (HtSDS) and their mid-parental height.
hrp0094p2-265
Linear growth and response to GH therapy in children with short stature with normal Growth hormone secretion: Comparison between children with delayed versus no delay in the bone age at diagnosis.
hrp0094p2-266
Linear growth and response to GH therapy in children with GHD with normal IGF-I versus those with normal GH secretion associated with low IGFI at presentation.
hrp0094p2-267
Growth response to growth hormone therapy in short children in relation to their distance from mid-parental heights (MPHt).
hrp0094p2-268
Immunogenicity of recombinant growth hormone therapy in the children with short stature and consequences on growth-promoting effect
hrp0094p2-269
Unified training materials to improve adherence to GH-treatment
hrp0094p2-270
Linear growth of prepubertal children born small for gestational age on growth hormone therapy for 3 years
hrp0094p2-271
Evaluation of the clinical and laboratory parameters and final adult height in patients treated with recombinant human growth hormone.
hrp0094p2-272
The results of treatment with growth hormone in a patient with growth hormone deficiency and type 1 diabetes
hrp0094p2-273
Aetiology and different clinical conditions of GHD in children in a region of North Africa
hrp0094p2-274
Growth hormone therapy in short stature: The variability of responses to treatment after one year. About 41 cases
hrp0094p2-275
Growth Hormone Resistance; The Iraqi experience
hrp0094p2-276
Growth and syndromes (to include Turner syndrome)
Response to growth hormone therapy with high IGF-1-levels and severe insulin resistance in two-cases with SOFT syndrome: A novel homozygous mutation in POC1A
hrp0094p2-277
Effects of growth hormone therapy on serum concentrations of IGF-1 in patients with Turner syndrome: High IGF-1 concentrations despite optimal dose?
hrp0094p2-278
The Effect of Hospital Admission and Nutritional Rehabilitation (NR) on Growth and Metabolic abnormalities in adolescent females with severe Anorexia Nervosa (AN)
hrp0094p2-279
Outcomes in growth hormone-treated Noonan syndrome children: impact of PTPN11 mutation status
hrp0094p2-280
Endocrinological assessment in patients with fanconi anemia
hrp0094p2-281
Brain-derived neurotrophic factor and matrix metalloproteinases as markers of metabolic status in girls with Turner syndrome.
hrp0094p2-282
Assessment of genetic defects, baseline characteristics and adverse events reported in the Increlex® registry
hrp0094p2-283
Associations between height and health-related quality of life (HRQoL) and functional independence in children with achondroplasia
hrp0094p2-284
COVID 19 impact on Pediatric Endocrinology care - a short story from Romania
hrp0094p2-285
Single nucleotide variations associated with short stature in Baka Pygmies as identified by Whole Exome Sequence (WES)
hrp0094p2-286
Novel
LZTR1
mutations in subjects with features of Noonan Syndrome and GH insensitivity negatively regulate GH-induced IGF-I production and hyperactivate GH-induced ERK1/2 activation in response to GH
in vitro
hrp0094p2-287
Comorbidities in Turner Syndrome patients controlled in our center since the 80’s
hrp0094p2-288
Familial Mosaic Turner Syndrome with short stature and spontaneous puberty due to a ring X chromosome with distal Xp22.3 and distal Xq26 deletion
hrp0094p2-289
Linear growth response to growth hormone therapy in underweight versus normal-weight children with idiopathic short stature (ISS)
hrp0094p2-290
Linear Growth and Weight gain in Infants with Significant Neonatal Hypoglycemia during the first two years of age: Comparison of infants of Diabetic Mothers (IDM) versus infants of non-diabetic mothers (INDM) with transient hyperinsulinemia (non-ketotic hypoglycemia)
hrp0094p2-291
Timing of infancy-childhood growth spurt in healthy Turkish children
hrp0094p2-292
Effects of GH replacement therapy on body composition and muscle health in children and adolescents with GH deficiency: one-year prospective case-control study.
hrp0094p2-293
The spectrum of the Prader-Willi-like pheno- and genotype
hrp0094p2-294
An Italian survey on GH stimulation tests and their adverse side effects.
hrp0094p2-295
Comparing the efficacy of nutritional supplementation of different caloric concentrations on linear growth and weight gain in late childhood, a longitudinal study.
hrp0094p2-296
The efficacy and safety of recombinant biosimilar growth hormone treatment in children with GHD and SGA: a Czech retrospective national longitudinal study
hrp0094p2-297
A qPCR based approach for rapid detection of Turner Syndrome and its variants
hrp0094p2-298
Case report: Tall stature, obesity and hip dysplasia in Weaver syndrome due to a loss-of-function variant in
EHZ2
hrp0094p2-299
Association of Daily Growth Hormone Injection Adherence and Height among Children with Growth Hormone Deficiency
hrp0094p2-300
The evaluation of growth velocity, height, weight, elementary laboratory tests and hormonal function in the patient with Floating-Harbor syndrome treated with growth hormone for 20 months -case report, preliminary report.
hrp0094p2-301
Two Sibling Cases with Growth Hormone Receptor Mutation: Variable Clinical Expressivity in Laron Syndrome
hrp0094p2-302
A literature review of the potency and selectivity of FGFR-selective tyrosine kinase inhibitors, such as infigratinib, in the potential treatment of achondroplasia
hrp0094p2-303
Impact of estrogen therapy on pubertal growth in Turner syndrome
hrp0094p2-304
Anastrozole improves height prediction and near final height as monotherapy or in combination with growth hormone
hrp0094p2-305
Growth hormone deficiency (GHD) with high circulating insulin-like growth factor-1 (IGF-1) in an adolescent with celiac disease: Is it IGF-1 insensitivity?
hrp0094p2-306
Postnatal Linear Growth and Weight Gain in Infants of Diabetic Mothers (IDM) Who Were Born at or Near Term and Had Severe Neonatal Hypoglycemia Without Other Comorbidities.
hrp0094p2-307
Evidence that non-syndromic familial tall stature has an oligogenic origin including ciliary genes
hrp0094p2-308
Early-onset growth hormone treatment in Prader-Willi syndrome attenuates the risk of transition to severe obesity
hrp0094p2-309
Incidental pituitary adenoma detection in two patients affected by Williams Syndrome: only a coincidence?
hrp0094p2-310
Efficacy of recombinant growth hormone therapy in TRPS 1 syndrome coexisting with growth hormone deficiency.
hrp0094p2-311
Results from the Implementation of a Growth Disorders Related Twinning Programme (Partners4Growth) at tertiary pediatric endocrinology clinics
hrp0094p2-312
Co-occurrence of Turner (46,X-ring/45,X0 mosaicism) and Mayer-Rokitansky-Kuster-Hauser Syndromes: a case report
hrp0094p2-313
Shox Gene Pathologies In Children With Short Stature And Madelung Deformity
hrp0094p2-314
Characteristics of Patients with Noonan Syndrome Carrying a PTPN11 Mutation: The Recombinant Growth Hormone Treatment and Long-Term Follow-up
hrp0094p2-315
Determining factors of a good response to treatment with growth hormone for the first 2 years
hrp0094p2-316
Noonan syndrome patients with short stature at a single pediatric endocrinology centre
hrp0094p2-317
Thyroid status in children with Turner syndrome
hrp0094p2-318
Rare case report: A Chinese boy with MDPL syndrome cause by
POLD1
gene mutation
hrp0094p2-319
An Unusual Case of Gastrointestinal Bleeding; Expecting the Unexpected
hrp0094p2-320
Alterations in Metabolic profile and Body Composition in children with Silver Russell syndrome
hrp0094p2-321
Growth abnormalities in patients with Type 1 diabetes
hrp0094p2-322
A novel CEP57 mutation of mosaic variegated aneuploidy syndrome in a Chinese girl: a case report and review of literature
hrp0094p2-323
A Patient with Turner Syndrome (45X/46XX) and Congenital Adrenal Hyperplasia: A Case Report and Literature Review
hrp0094p2-324
Impact of oral nutritional supplements on growth outcomes in underweight children (5: 12 years) with no systemic disease.
hrp0094p2-325
Differential diagnosis of pre- and postnatal short stature revisited: 3-M syndrome
hrp0094p2-326
A case of a Floating-Harbor syndrome in a child with severe short stature.
hrp0094p2-327
Excessive body hair, short stature and advanced bone age in a girl: Hypertrichosis versus adrenarche?
hrp0094p2-328
Cornelia de Lange syndrome: a case report
hrp0094p2-329
Short stature and efficacy of growth hormone treatment in a child with Nail-Patella Syndrome. A case report.
hrp0094p2-330
Final and Near-final Adult Height and BMI after Long-term Growth Hormone Treatment in Patients with Turner Syndrome (TS)
hrp0094p2-331
Evaluating Safety, Efficacy, and Pharmacokinetics of Weekly TransCon CNP in Children with Achondroplasia: Design of the ACcomplisH Trial
hrp0094p2-332
Multisystem endocrine disorders
An Early Diagnosis of Prohormone Convertase Deficiency
hrp0094p2-333
Serologic Testing for Celiac Disease and Gluten Intolerance in a Singaporean paediatric endocrine and growth clinic.
hrp0094p2-334
Obesity, vaginal bleeding and ovarian mass in a 5-year-old female girl with autoimmune hypothyroidism
hrp0094p2-335
Endocrine and metabolic complications according to genotype in Prader-Willi syndrome
hrp0094p2-336
Van Wyk Grumbach Syndrome in an Egyptian Female Pediatric Patient: a rare presentation of a common disease
hrp0094p2-337
Diagnostic and Follow-up Problems of Medical Care for Prader-Willi Syndrome Children in Resourse-Limited Settings
hrp0094p2-338
Three generations of MEN-1: the importance of family screening
hrp0094p2-339
Follow-up and management of endocrine and metabolic disorders after hematopoietic stem cell transplantation in a patient followed for Fanconi anemia
hrp0094p2-340
Neonatal McCune Albright Syndrome Presenting with Diabetes Mellitus
hrp0094p2-341
Combined pituitary hormone deficiency associated with Graves’ disease
hrp0094p2-342
Autoimmune polyendocrine syndrome type 2 and precocious puberty: a rare association
hrp0094p2-343
Thermoregulatory delays in Greek PCOS adolescents
hrp0094p2-344
Endocrine manifestations in familial neurofibromatosis type 1: a case report
hrp0094p2-345
Pituitary, neuroendocrinology and puberty
The clinical and biochemical spectrum of pituitary lesions in children compared to adults: experience from a single tertiary center
hrp0094p2-346
Optic tract glioma and endocrine disorders- comparison between patients with and without NF1- a single center experience
hrp0094p2-347
Endocrine manifestations of paediatric intracranial germ cell tumour: from diagnosis to long-term follow-up
hrp0094p2-348
Machine learning to detect the Klinefelter syndrome endocrine profile
hrp0094p2-349
Nuchal Skinfold Thickness in Pediatric Brain Tumor Patients
hrp0094p2-350
Growth hormone deficiency in 52 children with brain Magnetic Resonance Imaging Abnormalities
hrp0094p2-351
Patients with PWS and related syndromes display differentially methylated regions involved in neurodevelopmental and nutritional trajectory.
hrp0094p2-352
Clinical course of primary empty sella in children: a 10-year single-center experience
hrp0094p2-353
Relation between specific pubertal growth and breast maturation - a longitudinal study in healthy girls
hrp0094p2-354
Did Central Precocious Puberty Increase in COVID 19 Pandemic?
hrp0094p2-355
Delayed diagnosis of paediatric intracranial germ cell tumour (IC-GCTs)
hrp0094p2-356
Gonadotropin-releasing hormone analog treatment in children with idiopathic central precocious puberty: a pharmacovigilance study in a pediatric population.
hrp0094p2-357
Pubertal induction in girls with hypogonadism: preliminary prospective data of efficacy in patients with/without initial overnight estrogen replacement
hrp0094p2-358
Evaluation of pituitary/cranial imaging results of central-puberty precocious cases
hrp0094p2-359
In vivo magnetic resonance spectroscopy as a non-invasive tool for the identification of a sellar tumour in a boy with precocious puberty.
hrp0094p2-360
Rahman Syndrome: Hypopituitarism might be responsible for changing height pattern
hrp0094p2-361
Congenital hypopituitarism: the role of genetics
hrp0094p2-362
Pedigree analysis is essential for clarifying oligogenic transmission in a family with congenital hypogonadotropic hypogonadism (CHH)
hrp0094p2-363
Congenital hypogonadotropic hypogonadism associated with X-linked ichthyosis due to X-chromosome microdeletion identified by chromosomal microarray
hrp0094p2-364
Gonadotropin Flare with Different Depot GnRH Agonists: Comparative Analysis.
hrp0094p2-365
Hypothalamic obesity in children with craniopharyngioma
hrp0094p2-366
Duplication of Pituitary Gland-plus Syndrome presenting with a Transcranial Nasal Dermoid Cyst
hrp0094p2-367
Sterile Abscess Formation with Two Different GnRH Analogues: Three Case Reports
hrp0094p2-368
6-Month GnRHa Formulations Are a Good Choice During the COVID-19 Pandemic and Beyond
hrp0094p2-369
Size Matters: CAG Repeat Length of the Androgen Receptor Gene, Testosterone, and Male Adolescent Depression Severity
hrp0094p2-370
Is quail egg a potential endocrine disruptor?
hrp0094p2-371
The impact of the Covid-19 pandemic on the UK National Hypothalamic-pituitary Axis Tumour (HPAT) multidisciplinary meeting
hrp0094p2-372
Evaluation of Clinical, Laboratory and Radiological Findings in the Differential Diagnosis of Premature Telarche and Central Puberty Precocious
hrp0094p2-373
Crooke Cell Adenoma as a Rare Cause of Recurrent Cushing Disease: A Challenge in Treatment and Follow-up
hrp0094p2-374
Salivary sex steroids as markers of puberty in boys during late childhood and adolescence
hrp0094p2-375
Efficacy of cabergoline in the treatment of pituitary macroadenoma complicated in a 14-year-old girl.
hrp0094p2-376
Use of Tolvaptan in a child with SIADH post pituitary surgery
hrp0094p2-377
The effect of 3 years of Gonadotropin-Suppressive Therapy in Girls with Early Puberty: Height Z Score in Relation to Mid-Parental height Z score.
hrp0094p2-378
An Observational, Retrospective Study to Evaluate Long Term Safety and Effectiveness of Leuprorelin in the Treatment of Central Precocious Puberty
hrp0094p2-379
Abstract unavailable
hrp0094p2-380
Characterization of puberty development in a large cohort of patients with Noonan syndrome with molecular diagnosis
hrp0094p2-381
Pituitary tumors in children and adolescents: clinical and etiological profile
hrp0094p2-382
Langerhans Cell Histiocytosis with Isolated Central Diabetes Insipidus, Low Grade Fever and Sellar Erosion
hrp0094p2-383
Basal LH as a screening test for diagnosis of central precocious puberty
hrp0094p2-384
A Practical Method for the Evaluation of Childhood Hypophysitis: Pituitary Stalk/Basilary Artery Ratio
hrp0094p2-385
Blood Pressure in Girls with Central Precocious Puberty and GnRH Analog Therapy
hrp0094p2-386
Isolated central diabetes insipidus and periventricular nodular heterotopia in a 9-year-old girl
hrp0094p2-387
Central precocious puberty: clinical, etiologic and therapeutic features
hrp0094p2-388
Atypical Presentation of Pituitary Macroadenoma in an adolescent girl: Central Hypothyroidism and Attenuated Pubertal Growth Spurt.
hrp0094p2-389
A case of partially Empty Sella with hypopituitarism in a child
hrp0094p2-390
Cushing’s disease in paediatric patients: Diagnosis and evolution
hrp0094p2-391
Late Puberty In Children
hrp0094p2-392
First Morning Voided Urinary Gonadotropin Measurements for the Early Screening, Diagnosis and Follow-up of Central Precocious Puberty Patients
hrp0094p2-393
Sex differentiation, gonads and gynaecology or sex endocrinology
SRY negative 46XX male syndrome: case report
hrp0094p2-394
Cognitive function and linear growth in Prednisone-treated children with salt-wasting congenital adrenal hyperplasia
hrp0094p2-395
Combining big data science with clinics: Novel approach for understanding human sex development and its variants.
hrp0094p2-396
Vascular dysfunction and increased cardiovascular risk in hypospadias
hrp0094p2-397
Evaluation of genomic copy number variations in the etiology of syndromic patients with diferences of sex development (DSD)
hrp0094p2-398
Self-reported Feelings of Adult Patients with Differences of Sex Development (DSD) Regarding Genital Surgical Procedures
hrp0094p2-399
Peripheral Precocious Puberty in girls affected by McCune-Albright Syndrome: safety and efficacy retrospective study on letrozole treatment
hrp0094p2-400
Two sisters with primary hypergonadotrophic hypogonadism, pubertal progress and deletion of 61.5MB of Χq21.33q28 region
hrp0094p2-401
Description of a new variant in the MAMLD1 gene in an infant with microphallus and hypospadias
hrp0094p2-402
Surgical aspects of the multicentric and interdisciplinary study in minors with different sexual development
hrp0094p2-403
Is inflammation the major driver of polycystic ovary syndrome (PCOS)? A proteomic approach to understanding PCOS in adolescents and the search for novel non-invasive biomarkers
hrp0094p2-404
Serum high mobility group box 1 (HMGB1) levels are independently associated with glucose clamp-derived measures of insulin resistance in PCOS
hrp0094p2-405
ZSWIM7
is associated with human female meiosis and familial primary ovarian insufficiency
hrp0094p2-406
Is the recommended dual therapy for transsexual boys harmless?
hrp0094p2-407
Plexiform neurofibroma of the penis as an infrequent manifestation debut in a pediatric patient
hrp0094p2-408
Surprising X Chromosomes: Unusual Mosaicism
hrp0094p2-409
Puberty delay in girls: etiological structure of the disease
hrp0094p2-410
Rationale for a reduced dexamethasone dose in prenatal congenital adrenal hyperplasia therapy based on pharmacokinetic modelling
hrp0094p2-411
45,X/46,XY mosaicism: Phenotypic characteristics, growth, and gonadal features
hrp0094p2-412
Challenges faced by children and adolescents with Differences in Sex Development (DSD) managed at a tertiary care specialized university center in Sri Lanka
hrp0094p2-413
A novel mutation of SOX2 gene in an idiopathic hypogonadotropic hypogonadism patient with olfactory bulb agenesis
hrp0094p2-414
Obesity, ovarian mass, vaginal bleeding and hypothyroidism in a 5-year-old female girl
hrp0094p2-415
Ovarian Juvenile Granulosa Cell Tumor in 9-Month-Old female Infant presented with Isosexual Pseudo Puberty: Case Report
hrp0094p2-416
A case report of Non-syndromic 46, XX testicular DSD presenting as a genital ambiguity - Clinical, molecular and cytogenetic analysis
hrp0094p2-417
46 XX, SRY negative testicular DSD presenting with VACTERL Syndrome
hrp0094p2-418
A late revelation of Sexual differentiation disorder 46XX due to 11 beta hydroxylase deficiency
hrp0094p2-419
Gonadal tumor risk, bone mineral density, and genetics, clinical, hormonal, and psychosexual aspects of a large androgen insensitivity syndrome cohort
hrp0094p2-420
Radiological evaluation of children with atypical genitalia due to disorders of sex development (46, XY DSD) in a resource-limited setup
hrp0094p2-421
17-hydroxylase deficiency and diabetes in a case with 46 XY female
hrp0094p2-422
Diagnostic dilemma in a patient with central precocious puberty: Ovarian steroid cell tumor
hrp0094p2-423
Dimensional approach to gender dysphoria in nigeria: Association with socio-demographics and psycho-sexual variables
hrp0094p2-424
Puberty delay in girls: Analyses of disease structure depending on clinical characteristics
hrp0094p2-425
Uterus agenesia in a patient with CATCH 22 Syndrome. Purpose of a case
hrp0094p2-426
High throughput screening of DSD candidate genes with the help of the powerful model
Drosophila melanogaster
hrp0094p2-427
Case series: Use of tamoxifen in the management of gynaecomastia in three adolescent boys with 46 XY DSD
hrp0094p2-428
4-year-old female patient with mixed germ cell tumor and underlying Cowden syndrome
hrp0094p2-429
A comparison between Androstanolone and Testosterone Enanthate for penile augmentation in patients with idiopathic micropenis
hrp0094p2-430
Combination therapy of hypogonadotropic hypogonadism with rFSH and hCG – case report
hrp0094p2-431
46,XY DSD due to biallelic DHX37 gene mutations
hrp0094p2-432
Novel mutation in an iranian family with 17-β hydroxysteroid dehydrogenase type 3 deficiency
hrp0094p2-433
A case of gender developmental disorder with difficulty in molecular diagnosis: New variant in NR5A1 gene
hrp0094p2-434
Two pedigrees with congenital bilateral anorchia in one sibling and testicular torsion at adolescence in another: a shared genetic predisposition?
hrp0094p2-435
Importance of testicular biopsy for validation of diagnosis; cryptorchidism, analyzing prescrotal undescended testes
hrp0094p2-436
Rare genetic disorder associated with microphallus
hrp0094p2-437
Congenital adrenal hyperplasia in detail: A multicentric and interdisciplinary study in minors with different sexual development
hrp0094p2-438
Sex assignment at birth: is it always easy?
hrp0094p2-439
Combination therapy of hypogonadotropic hypogonadism in boys with rFSH and hCG – case reports analyses
hrp0094p2-440
Clinical case of premature ovarian failure in combination with blepharophimosis-ptosis-epicanthus inversus due to mutation in
FOXL2
gene
hrp0094p2-441
Persistent Müllerian duct syndrome presenting with bilateral cryptorchidism and obstructed inguinal hernia
hrp0094p2-442
5 alpha-reductase type 2 deficiency: A case report
hrp0094p2-443
An unexplained cause of unilateral gynecomastia in a 3-year-old boy
hrp0094p2-444
Could intramuscular testosterone differentiate between partial androgen insensitivity and 5 alpha reductase type 2 deficiency?
hrp0094p2-445
Thyroid
The efficacy and short- and long-term side effects of radioactive iodine treatment in pediatric Graves’ disease: a systematic review
hrp0094p2-446
Incidentally detected papillary thyroid cancer with elevated calcitonin in a 15 year-old female: A case report
hrp0094p2-447
Methimazole-induced remission rates in pediatric graves’ disease: A systematic review
hrp0094p2-448
Congenital multinodular goiter causing acute airway obstruction in a newborn: a case report
hrp0094p2-449
Initial response to thionamide medication in young people with newly diagnosed thyrotoxicosis
hrp0094p2-450
A girl with Trisomy 21 presents with Van Wyk-Grumbach syndrome. A rare diagnosis
hrp0094p2-451
Complications after pediatric thyroidectomy: lymph node dissection is a risk factor for permanent hypocalcemia
hrp0094p2-452
Kinetics of FT4 serum concentrations in newborns and infants with congenital hypothyroidism during follow-up differ in the three severity groups
hrp0094p2-453
Thyroid dysfunction in small for gestational age infants: a need for second screening?
hrp0094p2-454
Expression of Zinc transporter 8 in thyroid tissues from patient with immune and non-immune thyroid diseases
hrp0094p2-455
Hashimoto Thyroiditis: long term follow-up from childhood to young adulthood
hrp0094p2-456
A case of complete atrioventricular block after initiation of methimazole in a patient with Graves' disease associated with Down's syndrome previously undergoing cardiac surgery
hrp0094p2-457
Unilateral autoimmune ophthalmopathy as a first symptom in manifestation of autoimmune thyroiditis and systemic lupus erythematosus in an adolescent girl. Case report.
hrp0094p2-458
Incidence and etiology of primary congenital hypothyroidism in Flanders
hrp0094p2-459
Re-evaluation of the prevalence of permanent congenital hypothyroidism in Niigata, Japan: A retrospective study
hrp0094p2-460
Early reassessment in congenital hypothyroidism
hrp0094p2-461
Growth impairment in children with severe autoimmune primary hypothyroidism and pituitary hyperplasia without goiter
hrp0094p2-462
The Use Of Intravenous Introduction Of Glucocorticoids In The Active Stage Of Graves’ Ophthalmopathy In Childhood. Clinical Case
hrp0094p2-463
Atypical presentation of acute suppurative thyroiditis in a 6 year old child
hrp0094p2-464
Allan-Herndon-Dudley syndrome: case report of a rare disorder
hrp0094p2-465
Abstract unavailable
hrp0094p2-466
Abstract unavailable
hrp0094p2-467
Thyroid function in preterm infants admitted to the neonatal intensive care unit: a single center study
hrp0094p2-468
Thyroid dysfunction in Beta-thalassemia patients
hrp0094p2-469
Victim pathologies of the pandemic. Severe acquired hypothyroidism
hrp0094p2-470
Mitigating thyroid cancer risk in multinodular hyperplasia secondary to a 10q23.31 deletion (PTEN Hamartoma Tumour Syndrome)
hrp0094p2-471
Thyroid dysfunction and autoimmune thyroiditis in children with new-onset diabetes mellitus
hrp0094p2-472
A rare cause of congenital hypothyroidism: Brain-lung-thyroid syndrome
hrp0094p2-473
Recurrent fractures in a child with Graves' disease
hrp0094p2-474
Case study of 13- year-old boy suffering from papillary thyroid cancer in stage pT3aN1bMX
hrp0094p2-475
Evaluation of general characteristics of children with hypothyroidism
hrp0094p2-476
L-T4 absorption test in 14-year-old patient with severe refractory hypothyroidism after total thyroidectomy
hrp0094p2-477
A child with anti-thyroid arthritis syndrome
hrp0094p2-478
Thyroglobulin deficiency: a rare cause of neonatal stridor
hrp0094p2-479
TBG deficiency and Central Congenital Hypothyroidism (CCH): Our experience in neonatal screening with TSH and T4
hrp0094p2-480
A case of hypothyroidism post bone marrow transplantation
hrp0094p2-481
Iodine status and autoimmune thyroiditis in children; a case-control study in Sri Lanka
hrp0094p2-482
A 9-year-old girl with Van Wyk and Grumbach syndrome: precocious puberty as a rare consequence of hypothyroidism
hrp0094p2-483
Iodine Deficiency Cretinism in Tuva Republic
hrp0094p2-484
Prevalence and associated factors of Congenital Hypothyroidism in Bogotá, Colombia. 2014 - 2020
hrp0094p2-485
Aetiology and different clinical condition of hypothyroidism in children and adolescents
hrp0094p2-486
Influenza A induced Thyrotoxic Storm Post Haematopoietic Stem Cell Transplantation
hrp0094p2-487
The state of iodine deficiency in Krasnoyarsk territory according to results of neonatal TSH screening in 2019
hrp0094p2-488
Thyrotropic cell hyperplasia secondary to prolonged uncontrolled primary hypothyroidism
hrp0094p2-489
Thyroid dyshormonogenesis: a case report of two siblings with a heterozygous variant in the TPO gene.
hrp0094p2-490
Pediatric Graves’ disease in southern Tunisia
hrp0094p2-491